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The pH-low insertion peptide (pHLIP) and pH-low insertion cycle (pHLIC) have been 
shown to target cancer cells and inflammation due to the acidic environment present at 
those sites. It has been demonstrated that pHLIP’s and pHLIC’s pH dependent behavior 
stems from the protonation and deprotonation of aspartic acid (Asp) and glutamic acid 
(Glu) residues. A decrease in pH leads to the protonation of Asp/Glu located in 
membrane-inserting part of peptides, which increases the overall hydrophobicity of 
pHLIP and pHLIC and triggers the insertion across a lipid bilayer.  
Despite similarity of pHLIP and pHLIC ability to sense pH at cell surfaces the 
mechanisms of peptides insertion into membrane is different. pHLIP, which is a flexible 
polymer in solution at high pH, undergoes pH-triggered folding in membrane to 
transition from coil to transmembrane helix. pHLIC, which is a rigid cyclic peptide, 
undergoes pH-triggered partition into membrane without changes of its structure. 
pHLIP peptide insertion occurs in several steps, with a rapid interfacial helix formation 
(folding) completed within 100 ms followed by the rate limiting step of peptide insertion 
across membrane to form a transmembrane helix. Exit from the bilayer and unfolding is 
triggered by deprotonation of Asp/Glu residues induced by pH raise. The reverse process 
of unfolding and exit proceeds through different intermediate states. The detailed kinetics 
study of pHLIP variants pH-triggered insertion and exit from the membrane of liposomes 
allowed to elucidate the molecular mechanism of membrane-associated folding and 
unfolding, and design and test new pHLIP variants with tunable pH-dependent properties. 
Biophysical investigation of several pH-sensitive and pH-insensitive cyclic peptides led 
to the selection of best pHLIC candidate for targeting and imaging of neuroinflammation, 
which is associated with development of variety of neurodegenerative diseases. 
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A series of cyclic peptides containing a number of tryptophan (W) and glutamic acid (E) 
residues were synthesized and evaluated as pH-sensitive agents for targeting of acidic 
tissue and pH-dependent cytoplasmic delivery of molecules. Biophysical studies revealed 
the molecular mechanism of peptides action and localization within the lipid bilayer of the 
membrane at high and low pHs. The symmetric, c[(WE)4WC], and asymmetric, c[E4W5C], 
cyclic peptides translocated amanitin, a polar cargo molecule of similar size, across the 
lipid bilayer and induced cell death in a pH- and concentration-dependent manner. 
Fluorescently-labelled peptides were evaluated for targeting of acidic 4T1 mammary 
tumors in mice. The highest tumor to muscle ratio (5.6) was established for asymmetric 
cyclic peptide, c[E4W5C], at 24 hours after intravenous administration. pH-insensitive 
cyclic peptide c[R4W5C], where glutamic acid residues (E) were replaced by positively 
charged arginine residues (R), did not exhibit tumor targeting. We have introduced a novel 
class of cyclic peptides, which can be utilized as a new pH-sensitive tool in investigation 





Tissue acidity is linked to various pathological states such as ischemia, tumor, 
inflammation, arthritis, infection, atherosclerosis and others1–3. Tumor progression and 
development is associated with acidosis4–6. Extracellular acidity is established already at 
early stages of tumor development, during the avascular phase of carcinoma   in situ. As 
tumor continues to grow, acidosis is increasing due to the poor blood perfusion, switch of 
cancer cells to the glycolytic mechanism of energy production even in the presence of 
oxygen and overexpression of carbonic anhydrases (CA)7,8. Adaptations to the highly acidic 
microenvironment are critical steps in the transition from an avascular pre-invasive tumor 
to a malignant invasive carcinoma. Thus, targeting of acidity might serve as a predictive 
marker for tumor invasiveness and disease development. pH is especially lower in the 
vicinity of the mem- brane of cancer cells due to the work of proton pumps and 
CAIX/CAXII9. Also, pK of protonation of Asp and Glu residues is higher (pK ~ 6–7) near 
the surface of the hydrophobic membrane compared to bulk aqueous solution, where pK ~ 
3–410,11. The most effective pH-sensitive tumor targeting agents should sense pH at the 
surface of cancer cells, where it is the lowest12. There are a number of approaches under 
development for delivery of imaging and therapeutic agents to diseased tissue in a pH-
dependent manner. They are based on the use of pH-sensitive polymers, liposomes, 
nanoparticles and small molecules13–19. Among peptides, family of pHLIP peptides, linear 
peptides of 25–35 residues, which insert into cellular membrane and form transmembrane 
helices are used for targeting of acidic tumors of various origins and other acidic diseased 
tissues20. Application of cyclic peptides in biological sciences has become a subject of 
major interest because of their enhanced enzymatic stability versus linear peptides21. 
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Recently we reported the design and synthesis of homochiral L-cyclic peptides containing 
arginine (R), tryptophan (W) residues and their application for the nuclear targeting delivery 
of anti-HIV drugs, phosphopeptides, anticancer drugs, and siRNA22–24. These peptides 
offered several advantages including nuclear delivery of doxorubicin, low cytotoxicity, 
biocompatibility, hydrophobic drug entrapment through non-covalent interactions, and 
drug delivery through conjugation. Herein, we designed and introduced for the first time 
the pH-sensitive negatively charged cyclic peptides and studied their interactions with the 
lipid bilayer of liposomal and cellular membranes in vitro and in vivo. 
 
RESULTS 
Among the investigated peptides were one linear and six cyclic peptides (Fig. 1 and Table 
S1, Supplementary Information). All peptides contained: i) single cysteine (Cys, C) residue 
for conjugation purposes, ii) at least one tryptophan (Trp, W) for ability to record 
fluorescence signal, iii) 3–5 protonatable glutamic acid (Glu, E) residues to trigger pH-
dependent interaction with the membrane. Three peptides, c[(WE)3WC], c[(WE)4WC] and 
c[(WE)5WC] had 3, 4, and 5 repeating units of WE, respectively, where W and E were 
alternating in the cyclic of the peptide. Another peptide, c[(LE)4WC], had leucine (Leu, L) 
instead of Trp. The main goal was to investigate the role of aromatic Trp residues in 
peptide’s interaction with the membrane. Fifth peptide, c[E4W5C], was an asymmetric; it 
had five Trp residues located on one side of the cycle, while four Glu residues were located 
on the other side of the cycle. The positively charged cyclic peptide control, c[R4W5C], was 
also investigated, where Glu residues were replaced by positively charged arginine (Arg, 
R) residues. Finally, we synthesized one linear l(CW(EW)4) 10-residue peptide for the 
comparison with the cyclic peptides. The peptides were synthesized by employing 
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Fmoc/tBu-based solid phase chemistry. As representative examples, the synthesis of 
l(CW(EW)4 and c[(WE)4CW] peptides are depicted in the Scheme (Scheme S1, 
Supplementary Information). All peptides were purified (95–99%) by reverse phase HPLC.  
Fluorescence and CD spectroscopies were employed to monitor pH-dependent 
peptide’s interaction with the lipid bilayer of liposomes (Figures S1 and S2, Table S2). 
Biophysical studies were carried out at pH 8 and pH 3 to ensure completeness of the 
transitions, and to perform measurements in the states of thermodynamic equilibrium. All 
peptides demonstrated pH-dependent partitioning into the membrane. Asymmetric cyclic 
peptide with Trp residues located on one side of the cycle, c[E4W5C], most probably 
partitioned into the membrane facing Trp residues into the bilayer and exposing charged 
Glu residues to the extracellular space. The drop of pH led to the protonation of carboxyl 
groups of Glu residues, which increased peptides hydrophobicity and promoted further 
partitioning of the peptides into the bilayer. As a result, positions of maximum of 
fluorescence spectra shifted to 6–9 nm to short wavelengths, which is indicative of changes 
of microenvironment of Trp residues from polar to hydrophobic25,26 (Figure S1 and Table 
S2). c[(WE)3WC], c[(WE)4WC] and c[(WE)5WC] peptides showed similar CD signals at 
pH 8, which were altered by interaction with lipid bilayer and drop of pH. The CD signal 
of c[E4W5C] peptide was different but was also pH-dependent. We did not observe 
characteristic CD signal of exciton (delocalized, shared electron density) with a 
characteristic minimum at 232–235 nm27. Such an exciton might be formed only in a result 
of stacking of aromatic amino acids due to the cyclic peptide’s aggregation to form tubular 
structures. Thus, we concluded that at the concentrations of the peptides used in this study, 
the formation of tubular structures is unlikely. 
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By monitoring shift of the position of the maximum of fluorescence spectra for the 
peptides in the result of the pH drop, we established apparent pK of peptide’s partitioning 
into the bilayer. The pK for most cyclic and linear peptides varied in the range of 5.7–6.4, 
while the smallest pK value was observed for the cyclic Leu-containing peptide, 
c[(LE)4WC] (Fig. 2). 
To establish localization of the peptides within a lipid bilayer of membrane, dual 
quenching assay28 was employed (Fig. 3 and Table S3). Effective quenching of 
fluorescence by acrylamide would occur only for tryptophan residues exposed to polar 
parts of the outer or inner leaflets of the bilayer. At the same time, tryptophan residues 
located in the middle of a membrane would be effectively quenched by 10-DN. The result 
of the dual quenching assay allows establishing if tryptophan residues were located in the 
middle of a membrane or close to the polar headgroups of the bilayer. However, it does not 
allow distinguishing between locations    at the outer or inner leaflets of the bilayer. 
Therefore, we also performed Förster resonance energy transfer (FRET) assay29 (Fig. 4). 
First, symmetrically-labelled by NBD dye, POPC liposomes were prepared. Then, 
membrane-impermeable dithionite was used to chemically modify exposed NBD, which 
led to the quenching of NBD fluorescence. Thus, NBD dyes located at the outer leaflet of 
the bilayer were deactivated and excess of dithionite was removed by gel filtration. As a 
result, asymmetrically-labelled liposomes with active NBD at the inner leaflet were 
obtained. FRET was monitored from tryptophan residues of the peptides to NBD. Energy 
transfer might occur only when both fluorophores are in proximity to each other (within 5–
15 Å). Thus, when tryptophan residues located at the outer leaflet of the bilayer no 
significant energy transfer to NBD at the inner leaflet would occur (the distance is about 
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50–60 Å). The c[E4W5C] demonstrated the highest quenching by 10-DN and the highest 
FRET at pH 8 indicating the internal position of Trp residues within the bilayer of a 
membrane. All other peptides were located at the outer leaflet of the bilayer at pH 8. Drop 
of pH promoted partitioning of all cyclic peptides into bilayer, which highest FRET for the 
c[E4W5C] at pH 3. Among c[(WE)3WC], c[(WE)4WC] and c[(WE)5WC] peptides, the 
peptide with the smallest cycle, c[(WE)3WC], showed the deeper partitioning into the 
membrane. Linear peptide, l(CW(EW)4), also demonstrated some partitioning into bilayer 
in the result of the pH drop. 
Since all peptides exhibited pH-dependent interactions with the lipid bilayer of 
membrane and no cytotoxicity was observed (Figure S3), we proceeded to the experiments 
on cultured cancer cells. Symmetric, c[(WE)4WC], and asymmetric, c[E4W5C], cyclic 
peptides were evaluated for their ability to move polar cargo across the membrane. The 
experiments on live cells were performed at physiologically relevant pHs, such as pH 7.4 
(extracellular pH of normal cells) and pH 6.0 (extracellular pH in the vicinity of cancer 
cells12). As a polar cargo, we used amanitin, which is a cell-impermeable cyclic peptide of 
molecular mass similar to the masses of investigated pH-sensitive cyclic peptides. 
Amanitin is a deadly toxin, which inhibits RNA polymerase II if transferred across the lipid 
bilayer of the plasma membrane30. The pH- and concentration-dependent cell death was 
observed after treatment of HeLa cells for just 3 hours with c[(WE)4WC]-S-S-amanitin 
(c[(WE)4WC]-SPDP-amanitin) and c[E4W- 5C]-S-S-amanitin (c[E4W5C]-SPDP-amanitin) 
(Fig. 5a,b). The calculated IC50 values for symmetric cyclic pep- tide amanitin construct, 
c[(WE)4WC]-S-S-amanitin, at pH 7.4 and 6.0 were 3.39 ± 0.12 μM and 1.06 ± 0.02 μM, 
respectively. The calculated IC50 values for asymmetric cyclic peptide amanitin 
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construct, c[E4W5C]-S-S-amanitin, at pH 7.4 and 6.0 were 1.68 ± 0.13 μM and 0.74 ± 0.08 
μM, respectively. Previously we showed that amanitin alone does not induce cell death at 
the concentrations used in this study and for the duration of treatment of 2–4 hours31. We 
also tested construct, where amanitin was conjugated to the asymmetric c[E4W5C] cyclic 
peptide via non-cleavable bond (c[E4W5C]-GMBS-amanitin) (Fig. 5c). The cytotoxic effect 
for the non-cleavable construct was reduced significantly at both pHs. It might indicate that 
the peptide-amanitin construct remained within the membrane and cleavage of amanitin 
from the peptide was required to allow amanitin to reach RNA polymerase II in the nucleus. 
Alternatively, if peptide-amanitin was translocated into the cytoplasm, the cleavage of 
amanitin might be required, since affinity of the peptide-amanitin to the RNA polymerase II 
might be reduced compared to the affinity of free amanitin to the RNA polymerase II.  
Based on the obtained results, we proposed that at high/normal pH cyclic peptides 
were located at the outer leaflet of the bilayer. Triggered by pH drop the protonation of Glu 
residues enhanced peptide’s hydrophobicity and induced partitioning of the peptides into 
the bilayer of the membrane. This assumption was further con- firmed by quenching of 
fluorescence of FITC-labelled asymmetric cyclic peptide by cell impermeable Trypan Blue 
(Fig. 5d). Trypan Blue is used to quench fluorescence of FITC located in the extracellular 
space32. Cells treated with the FITC-labelled peptide at low pH followed by Trypan Blue 
quenching showed higher fluorescent signal on cells opposed to the cells treated with the 
FITC-labelled peptide at normal pH followed by Trypan Blue quenching. It indicates that 
at normal pH FITC is more exposed to extracellular space (to Trypan Blue) in contrast to 
low pH treatment. Since FITC fluorescence is a pH-sensitive and significantly quenched 
at low pH (pH 5.0–5.5) in endosomal compartment, we concluded that the FITC-labelled 
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peptide was localized at the inner leaflet of the plasma membrane rather than in endosomes. 
Also, the cellular uptake of Alexa546-labelled c[E4W5C] peptide at normal and low pHs in 
presence and absence of FBS was investigated (Fig. 5e). We observed statistically 
significant difference in cellular uptake of peptide at normal and low pHs, and no reduction 
of the uptake in the presence of FBS. 
Next we proceeded to animal studies to identify the lead peptide demonstrating best 
tumor targeting. The murine 4T1 xenograft model, which closely mimics stage IV of 
human breast cancer33,34, was used in our study. Small 4T1 tumor (tumor volume <150 
mm3) generates a significant level of lactate and serves as a good model of an aggressive, 
acidic tumor35. All peptides were covalently conjugated with Alexa546-malemide. The 
fluorescent constructs were given as a single IV injection, and at 4 hours after 
administration, animals were euthanized followed by necropsy. The mean fluorescence of 
tumor, muscle, kidney, liver and lungs were recorded and analyzed (Fig. 6). The least 
targeting was observed for Leu-containing peptide, c(LE)4CW. At the same time, the 
highest tumor targeting was monitored for linear peptide, l(CW(EW)4), symmetric, 
c[(WE)4WC], and asymmetric, c[E4W5C], cyclic peptides. 
To prove pH-dependent tumor targeting of WE cyclic peptides we tested positively-
charged asymmetric cyclic peptide, c[R4W5C], where Glu residues were replaced by Arg 
residues. This WR-peptide interacted with the lipid bilayer of the membrane at high pH 
(Figure S4) due to the presence of Trp residues, similar to WE-peptide. At the same time, 
it does not exhibit pH-dependent changes in interaction with the lipid bilayer of membrane, 
thus it can serve as a pH-insensitive control for pH-sensitive WE-cyclic asymmetric 
peptide, c[E4W5C]. 
10 
We performed side-by-side 4T1 tumor targeting and biodistribution investigation 
of asymmetric pH-sensitive, c[E4W5C], and pH-insensitive, c[R4W5C], peptides. A 
significant difference in tumor targeting was observed at all-time points after IV 
administration of the constructs (Figs 7a and S5). It resulted in a significant difference 
between tumor/organ ratios for pH-sensitive and insensitive peptides (Fig. 7b and Table 
S4). The accumulation of the pH-insensitive peptide in tumor and other organs was very 
minimal and varied in the range of 0.8 to 1.6 values, which could be attributed to the passive 
diffusion with blood flow. We have introduced a novel class of cyclic peptides, which 
demonstrate pH-sensitive interaction with lipid bilayer of membrane of liposomes, cultured 
cancer cells and tumors in animal model. We tested six cyclic peptides of three different 
cycle sizes, and different localization of Trp, Glu, Leu and Arg residues within the cycles. 
The size of investigated peptides is an optimal for the straightforward synthesis. The 
significantly smaller or larger sized cycles are more challenging to synthesize. The 
interaction of cyclic peptides with lipid bilayer of membrane has different mechanism 
compared to the action of linear pH-sensitive peptides such as pHLIP peptides. Negatively 
charged Glu residues of cyclic peptides, especially asymmetric one, which showed the best 
pH-dependent performance, are exposed to the aqueous solution at normal pH. At the same 
time, indole rings of Trp residues most probably interact with the lipid headgroups (Figs 8 
and S6). It was demonstrated previously that aromatic Trp residues have high affinity to 
lipid headgroups11,36–39. Our biophysical titration data indicate that c[E4W5C] cyclic 
peptide partitions into the lipid bilayer at pH 8. About 7.3 kcal/mol of free energy is 
released during the process (Figure S7), which indicates on strong interactions of the 
peptide with the membrane. The high affinity of the peptides to the cellular membranes at 
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normal pH might explain long time of circulation in mice. When pH is lowered, Glu 
residues are protonated. The pK of Glu residue protonation in the vicinity of the 
hydrophobic membrane is higher compared to the pK in a solution. Protonation leads to 
the increase of hydrophobicity of the peptide, which promotes partitioning of the peptide 
into the bilayer. As a result, about 0.7 kcal/mol of additional free energy is released at low 
pH (Figure S7). This energy could be used to move cell-impermeable cargo, such as 
amanitin, across membrane and target acidic tumors. Because Trp residues have higher 
affinity to the headgroups region compared to the central hydrophobic part of the bilayer, 
the peptide is equilibrated in the regions of head- groups between inner and outer leaflets 
of the bilayer. We and others showed that pH equilibrates fast inside a liposome40,41. Thus, 
an equal amount of the peptide molecules is distributed between both leaflets of the 
liposomal membrane with low pH outside and inside of it (Figure S6). However, in the 
case of live cells, pH inside a cell is normal (7.2–7.4), while bulk extracellular pH is slightly 
lower (6.5–6.8)42–44. However, the pH is at its lowest at the surfaces of cells9 and increases 
with distance from the cellular membrane, becoming normal in the vicinity of blood 
vessels45. Recently, we were able to measure in vitro and in vivo pH in the vicinity of 
plasma membrane of cancer cells, the pH values drops to 6.0–6.5 at the surface of cancer 
cells12. The most aggressive cancer cells are the most acidic. Thus, peptides reaching inner 
leaflet of the bilayer could expose their Glu residues to the cytoplasm, where they are 
expected to be de-protonated and became charged again. It would reduce the rate of the 
peptide diffusion back into the membrane and should lead to the shift of the equilibrium 
toward the accumulation of the peptides at inner leaflet of bilayer of the plasma membrane 
of cells (Fig. 8).  
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Thus, cyclic peptides could be considered as a weak acid with multiple protonatable 
groups, which can diffuse across the bilayer. For weak acids, the intracellular-extracellular 







  (1) 
 
where pHi and pHe are the intracellular and extracellular pH values, respectively. Since the 
have affinity to the membrane, we consider Ci and Ce as the concentrations of the peptide 
on inner and outer leaflets, respectively. We established the pKa of membrane partition for 
the asymmetric cyclic peptide, which equals to 5.7. The calculation shows that at pHe = 7.4 
and  pHi = 7.2 the concentration ratio at the inner and outer leaflets for asymmetric cyclic 
peptides is 0.6. However, the same ratio increases to 4.5, 7.8, and 10.9 if extracellular pHe 
would be 6.5, 6.2 and 6.0, respectively. We assume that the symmetrical WE peptides have 
the same mechanism of action as an asymmetric peptide, however they have less favorable 
localization of Trp and Glu residues, which reduces their ability to accumulate at the inner 
leaflet of bilayer of cellular membranes and target acidic tumors. Leu-containing peptides 
are less advantageous due to their reduced affinity to the headgroup part of the bilayer and 
high affinity to the center of the membrane. 
A novel class of pH-sensitive cyclic peptides containing tryptophan and glutamic 
acid residues have potential applications for targeting tumors and translocation of polar 
cargo molecules across cellular membrane. These peptides might have application not only 
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in targeting of acidic diseased tissue, they might find very interesting applications in 
cosmetics. It is well known that the natural skin surface pH is on average below 546. Thus, 
topical application of short (8–10 residues long), very stable cyclic peptides might open an 
opportunity to tether various cosmetic and skin care products to the skin surface.  
 
METHODS 
Materials. The materials including Fmoc-L-amino acid building blocks, preloaded amino 
acids on 2-chlorotrityl resin as solid support, and 2-(1H−benzotriazol-1-yl)-1,1,3,3-
tetramethyluronium hexafluoro- phosphate (HBTU) used for coupling reagents were 
purchased from Chem-Impex Int’l Inc., Wood Dale, IL. Piperidine and N-
methylmorpholine were purchased from Sigma-Aldrich Chemical Co. (Milwaukee, WI). 
The other chemicals such as N,N-diisopropylethylamine (DIPEA), cleavage cocktail 
reagents trifluoroacetic acid (TFA), 1-hydroxy-7-azabenzotriazole (HOAt), N,N′-
diisopropylcarbodiimide (DIC), acetic acid (AcOH), 2,2,2-trifluoroethanol (TFE), anisole, 
thioanisole, ethanedithiol (EDT), and anhydrous solvents such as N,N- dimethylformamide 
(DMF), dichloromethane (DCM), hexane, acetic acid (AcOH), and 2,2,2-trifluoroethanol 
(TFE) were purchased from Fisher Scientific, Pittsburg, PA. 
Methodology of Peptide Synthesis. In brief, the linear protected peptide was first 
assembled. Direct cleavage of peptide-attached resin in the presence of AcOH/TFE/DCM 
(1:2:7 v/v/v) generated the linear peptide. Cyclization in dilute condition using DIC/HOAt 
in DMF/DCM solution for 12 hours, followed by the depro- tection of the side chain by 
using cleavage cocktail (TFA:thioanisole:anisole:EDT (90:5:2:3 v/v/v/v) afforded the 
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cyclic peptide. The peptides were synthesized by employing the N-(9-
fluorenyl)methoxycarbonyl (Fmoc)-solid phase chemistry using PS3 automated peptide 
synthesizer (Rainin Instrument Co., Inc.) at room temperature. The peptide sequence was 
assembled on preloaded amino acid on 2-chlorotriyl resin using coupling, activating, and 
deprotecting reagents using HBTU, N-methylmorpholine (0.4 M), and piperidine in DMF 
(20% v/v), respectively. The amino acids in the peptide sequence were coupled using 
coupling reagents and activating reagent in DMF for 1 hour followed by washing with 
DMF 3 times. The deprotection was carried using piperidine (20%, v/v) in DMF for 2 
times, 10 minute for each time, followed by washing with DMF (3 times). The appropriate 
sequence of linear protected peptide was assembled using the synthesizer. N- to C-terminal 
cyclization of peptide were achieved by cleavage of protected peptidyl resin by stirring the 
peptidyl resin in freshly prepared cleavage cocktail of AcOH/TFE/DCM (1:2:7, v/v/v) for 
1 hour at room temperature followed by washing the resin with TFE:DCM (2:8 v/v, 2 
times). The collected filtrate was evaporated using a rotary evaporator followed by 
azeotropic removal of acetic acid by addition of hexane and dichloromethane to afford high 
viscous liquid or solid-protected linear peptide. The crude linear protected peptide was 
dissolved in excess of solvents DMF:DCM (4:1 v/v) followed by the addition of HOAt/DIC 
(1:1.1 equiv) for cyclization for 12–48 hours confirmed by MALDI TOF-TOF mass 
spectrometry. The solvent was evaporated under high reduced pressure in a rotatory 
evaporator at 40–45 °C to remove DMF. The final cleavage of side chain protection from 
the peptide were carried out after confirming the peptide cyclization by MALDI mass 
spectrometer data by shaking the cyclized peptide mixture in cleavage cocktail reagent R 
(TFA/thioanisole/anisole/EDT (90:5:2:3 v/v/v/v, 10–15 mL) for 2–4 hours followed by 
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pre- cipitation of peptide using cold ether, centrifugation at 2500 rpm and washing with 
excess of cold ether at 25 °C for 5 min. The crude peptide was purified with semi 
preparative reversed phase high performance liquid chro- matography (RP-HPLC) by 
using Hitachi L-2455 on a C18 Phenomenex Prodigy reversed-phase column (10 μ m, 250 
cm × 21.2 cm). The pure peptide was eluted at 15.0 mL/min using a gradient of binary 
solvent system using water and acetonitrile with 0.1% TFA for 0–100% over 60 min. The 
pure collected peptide fractions were pooled and lyophilized to provide solid powder in 
purity of ≥98%. All peptides were characterized by using high resolution time of flight 
AXIMA-performance MALDI TOF-TOF mass spectrometer (Shimadzu). The above 
mentioned protocol was applied for the synthesis of all cyclic peptides. The concentration 
of the peptides was calculated spectrophotometrically by measuring absorbance at 280 nm. 
The extinction coefficients, ε280, M−1 cm−1, for the peptides are the following: 
c[(WE)4WC] = 28,000; c[(WE)5WC] = 33,600; c[(WE)3WC] = 2,400; c[(LE)4WC] = 
5,600; c[E4W5C] = 28,000; l(CW(EW)4) = 28,000. 
Synthesis of Cyclic Peptides. The linear peptide sequence was synthesized on PS3 
automated synthesizer as described above in the scale of 0.3 mmol. H-Trp(Boc)-2-
chlorotrityl resin (384.6 mg, 0.3 mmol, 0.78 mmol/g) was swelled in DMF, followed by 
coupling and deprotection cycles to assemble respective amino acids on the pep- tidyl resin 
using respective amino acids, such as Fmoc-Glu(OtBu)-OH (382.9 mg, 0.9 mmol), Fmoc-
Trp(Boc)-OH (473.9 mg, 0.9 mmol), Fmoc-Cys(Trt)-OH (527.1 mg, 0.9 mmol), and 
HBTU (341 mg, 0.9 mmol) as the coupling reagent. Fmoc group of N-terminal in the 
peptidyl resin was removed using deprotection cycle, and the resin was transferred to 100 
mL round bottom flask. The linear protected peptide was cleaved by shaking peptidyl resin 
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in cleavage cocktail AcOH/TFE/DCM (1:2:7 v/v/v, 50 mL) for 1 hour followed by washing 
the resin using TFE:DCM (2:8 v/v, 10 mL, 2 times). The combined filtrate was evaporated 
to dryness with the subsequently addition of hex- ane (50 mL × 3) and DCM (10 mL × 3) 
to remove acetic acid, which provided solid white crude protected peptide ready for 
cyclization. The cyclization was carried out by dissolving the solid peptide in anhydrous 
DMF/DCM (250 mL, 4:1 v/v) under nitrogen using DIC (155.0 μL, 0.99 mmol) and HOAt 
(122.5 mg, 0.9 mmol) with stirring at room temperature for 24 hours. The cyclized product 
was confirmed by taking a small aliquot of the reaction mixture and cleavage with reagent 
R and using MALDI. After cyclization was confirmed, the solvents were evap- orated 
under high reduced pressure, and the side chain protections were removed by addition of 
cleavage cock- tail of reagent R, TFA/thioanisole/anisole/EDT (15 mL, 90:5:2:3 v/v/v/v), 
and shaking at room temperature for 3 hours. The peptides were precipitated, centrifuged, 
and washed with cold diethyl ether to yield the crude white solid peptide. The peptides 
were dissolved in H2O/CH3CN with 0.1% TFA and purified using RP HPLC. Then, the 
pure fractions were collected, concentrated and lyophilized to afford pure solid white 
powder of c[(WE)4WC] peptide. MALDI-TOF (m/z) [C78H83N15O18S]: calcd, 1549.6; 
found, 1572.3 [M + Na ]+; c[(WE)5WC]: MALDI-TOF (m/z) [C94H100N18O22S]: calcd, 
1864.7; found, 1865.4 [M + H]+; c[(WE)3WC]: MALDI-TOF (m/z) [C62H66N12O14S]: 
calcd, 1234.5; found, 1234.7 [M]+; c[(LE)4WC]: MALDI-TOF (m/z) [C58H87N11O18S]: 
calcd, 1257.6; found, 1258.2 [M + H]+; c[E4W5C]: MALDI-TOF (m/z) [C78H83N15O18S]: 
calcd, 1549.6; found, 1549.1  [M]+. A similar procedure was used for the synthesis of 
c[R4W5C] except using Fmoc-Arg(Pbf)-OH instead of Fmoc-Glu(OtBu)-OH. c[R4W5C]: 
MALDI-TOF (m/z) [C82H103N27O10S]: calcd, 1657.8; found, 1658.5 [M + H]+. 
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Synthesis of l(CW(EW)4). The linear peptide was assembled as described above using H-
Trp(Boc)- 2-chlorotrityl resin (384.6 mg, 0.3 mmol 0.78 mmol/g) in reaction vessel. The 
peptide sequence was assem- bled using the appropriate amino acid building blocks Fmoc-
Glu(OtBu)-OH (382.9 mg, 0.9 mmol), Fmoc-Trp(Boc)-OH (473.9 mg, 0.9 mmol), Fmoc-
Cys(Trt)-OH (527.1 mg, 0.9 mmol), and HBTU (0.9 mmol, 341 mg) as the coupling 
reagent. The final N-terminal Fmoc group was deprotected. The peptide was cleaved from 
the resin and side chain was deprotected by reaction of the peptidyl resin with freshly 
prepared cleavage cocktail reagent R, TFA/thioanisole/anisole/EDT (15 mL, 90:5:2:3 
v/v/v/v), for 3 hours at room temperature. The linear protected peptide was precipitated, 
centrifuged, and purified by using RP-HPLC as mentioned above to yield l(CW(EW)4). 
MALDI-TOF (m/z) [C78H85N15O19S]: calcd, 1567.6; found, 1606.1 [M + K]+. 
Labeling of Peptides with Fluorescent Dyes. Peptides were conjugated with Alexa546- 
and Fluorescein- 5-maleimide (Life Technologies) in DMF at a ratio of 1.2:1 and incubated 
at room temperature for about 6 hours and then at 4 °C until the conjugation reaction was 
completed. 50 mM of sodium phosphate/150 mM NaCl buffer pH 7.0 (saturated with 
argon) was added to the reaction mixture (1/10 of the total volume). The reaction progress 
was monitored by the reverse phase HPLC. The products were purified by the reverse phase 
HPLC, lyophilized and characterized by SELDI-TOF mass spectrometry. The 
concentration of the constructs was deter- mined by absorbance at 556 and 494 nm using 
molar extinction coefficients of 93,000 M−1·cm−1 for Alexa546 and 68,000 M−1·cm−1 
for Fluorescein-5 (FITC). 
Synthesis of Peptide-Amanitin Constructs.   We conjugated symmetric c[(WE)4WC] and 
asymmetric c[E4W5C] peptides with alpha-amanitin (Sigma-Aldrich) via cleavable S-S 
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bond. Furthermore, asymmetric c[E4W5C] peptide was labelled with amanitin via non-
cleavable bond. The conjugation scheme consisted of 2 steps: i) OH group of amanitin was 
conjugated with NHS group of the cleavable crosslinker, SPDP, N-succinimidyl 3-(2-
pyridyl-dithio)-propionate or the non-cleavable crosslinker, GMBS, N-γ-
maleimidobutyryl-oxysuccinimide ester (both crosslinkers were from (Thermo Scientific) 
in 50 mM sodium phosphate/150 mM NaCl buffer pH 8.0 at a ratio 1:20 at room 
temperature for 4 hours to get SPDP-amanitin or GMBS-amanitin. The products were 
purified by the reverse phase HPLC on Zorbax SB-C18 column (9.4 × 250 mm, 5-Micron). 
SPDP-amanitin was eluted using a gradient: 0–25%, 40 min (water and acetonitrile with 
0.05% TFA) and lyophilized. c[(WE)4WC] and c[E4W5C] peptides were incubated with 
SPDP-amanitin or GMBS-amanitin in 100 mM sodium phosphate/150 mM NaCl buffer 
pH 7.8 (saturated with argon) at a ratio 1:1 at room temperature for 1 hour to obtain 
amanitin-SPDP-peptides or amanitin-GMBS-peptide, respectively. The products were 
purified by the reverse phase HPLC on Zorbax SB-C18 column (9.4 × 250 mm, 5-Micron) 
using gradient 10–55%, 40 min (water and acetonitrile with 0.05% TFA). The products 
were lyophilized and characterized by SELDI-TOF mass-spectrometry. The calculated and 
obtained masses for the peptides were the following: c[E4W5C]-SPDP-amanitin: SELDI-
TOF (m/z) [C120H139N25O33S3]: calcd, 2553.9; found 2555.5 [M + H]+; c[E4W5C]-GMBS-
amanitin: SELDI-TOF (m/z) [C125H144N26O35S2]: calcd, 2632.9; found 2634.6 [M + H]+, 
and 2657.8 [M + Na]+; c[(WE)4WC]-SPDP-amanitin: SELDI-TOF (m/z) 
[C120H139N25O33S3]: calcd, 2553.9; found 2554.5 [M + 1]+. 
Liposome Preparation. Large unilamellar vesicles (LUVs) were prepared by extrusion. 
POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (Avanti Polar Lipids), or a 
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mixture of POPC with 0.5% of 18:1 NBD-PE, 1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine-N-7-nitro-2-1,3-benzoxadiazol-4-yl ammonium salt (Avanti Polar 
Lipids) were dissolved in chloroform, desolvated on a rotary evaporator, and dried under 
high vacuum for several hours. The phospholipid film was then rehydrated in 10 mM 
phosphate buffer pH 8.0, vortexed until the lipid bilayer was completely dissolved, and 
repeatedly (15–21 times) extruded through the membranes with 50 nm pore sizes to obtain 
LUVs. 
Steady-State Fluorescence and CD.    Freshly prepared peptides and POPC vesicles were 
mixed to have 5 μM of a peptide and 1.25 mM of lipids in the final solution. Steady-state 
fluorescence measurements were carried out on a PC1 spectrofluorometer (ISS, Inc.) under 
temperature control at 25 °C. Tryptophan fluorescence was excited at 280 nm (there is no 
Phe or Tyr in the peptides) and recorded with the excitation and emission slits set at 1 nm. 
The polarizers in the excitation and emission paths were set at the “magic” angle (54.7° 
from the vertical orientation) and vertically (0°), respectively. Steady state CD 
measurements were carried out in MOS 450 spectropolarimeter (Bio-Logic, Inc.) with the 
same concentrations of peptide and lipids used in fluorescence measurements. 
pH-Dependence. pH-dependent partitioning of the peptides into a lipid bilayer of the 
membrane was investigated by the shift of the position of the fluorescence spectral 
maximum for the peptides in the presence POPC liposomes induced by a drop of pH from 
8 to 2.5 by the addition of HCl. The peptides were incubated overnight with 50-nm POPC 
liposomes (final concentration of the peptides and POPC in solution was 5 μM and 1 mM, 
respectively), and pH decrease was achieved by the addition of aliquots of 4, 2, 1 and 0.1 
M HCl. pH was measured by micro-electrode probe (Thermo Electron Corporation, Orion 
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Ross Micro pH electrode). Fluorescence spectra were recorded at each pH value. The 
spectra were analyzed by the decomposition algorithms using on-line PFAST toolkit47 
(Protein Fluorescence and Structural Toolkit: http://pfast.phys.uri.edu/) to establish the 
position of the emission maximum. Finally, the positions of the fluorescence spectral 
maxima (λmax) were plotted versus pH, and the Henderson–Hasselbalch equation was used 
to fit the data (using Origin 8.5 software): 
 
𝜆𝑚𝑎𝑥 = 𝜆1𝑚𝑎𝑥 +
(𝜆1𝑚𝑎𝑥−𝜆2𝑚𝑎𝑥
1+10(𝑝𝐻−𝑝𝑘𝑎)
            (2) 
 
where λ1max and λ2max are the beginning and the end of the transition, respectively, and pKa 
– is the midpoint of the transition. 
Titration. Samples containing 5 μM of peptides at pH 8 and pH 3, and varying 
concentrations of lipids of the 50 nm POPC liposomes were prepared. The fluorescence 
spectra of peptides in all samples were measured at 280 nm excitation at 25 °C. A series of 
POPC blanks with the same concentrations of lipids were measured with the same 
instrument settings and were subtracted from the corresponding fluorescence spectra of 
peptides in the presence of POPC. The areas under the emission spectra were calculated 
and the values were normalized to the first point (the emission of the peptide in the absence 
of POPC). The titration data were fitted by the peptide-membrane partition model to 
calculate the mole-fraction partition coefficient, K  
𝐹 = 𝐹0 + ∆𝐹
𝐾∙𝐶𝑙𝑖𝑝
𝑊+𝐾∙𝐶𝑙𝑖𝑝
                  (3) 
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 F0 is the fluorescence intensity at zero concentration of lipids (in our case F0 = 1); ΔF if 
the fluorescence increase in the result of the titration with lipids; Clipids is the concentration 
of lipids; W is the molar concentration of water (55.3 M). Nonlinear least squares curve 
fitting procedure using Levenberg-Marquardt algorithm was implemented in Origin 8.5.0 
SR1. The Gibbs free energy (ΔG) was calculated according to the equation: 
 
∆𝐺 = −𝑅𝑇 ∙ ln⁡(𝐾)                     (4) 
where R is the gas constant and T is the temperature in Kelvin. 
 
Dual Quenching. POPC liposomes without and with 10% of the lipids replaced by 10-
doxylnonadecane (10-DN) (Avanti Polar Lipids) were prepared in 10 mM citrate-
phosphate buffer pH 8.0. Peptides and POPC liposomes were mixed to generate final 
concentrations of 7 μM peptide and 2.1 mM POPC without and with 10-DN. In some of 
the samples, the pH was lowered to pH 4 by addition of aliquot of 2 M citric acid, and other 
samples were kept at pH 8. Quencher, acrylamide (Sigma-Aldrich), was added to the 
samples of POPC liposomes containing no 10-DN, to have final concentration of 235 mM 
acrylamide. Concentration of peptides in all samples was kept constant. To observe 
quenching of tryptophan fluorescence by 10-DN or acrylamide, the tryptophan 
fluorescence was recorded as described above. The appropriate POPC blanks were 
measured and subtracted from the measured spectra before analysis. The percentage of 
quenching was calculated. 
NBD-FRET. First, symmetrically NBD-labelled POPC liposomes containing 0.5% of 
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NBD-PE were prepared. Next, 1.2 mL of 6 mM of symmetrically NBD-labelled POPC 
liposomes were incubated with 150 μL of 1 M freshly prepared membrane-impermeable 
dithionite in buffer at pH 8.0 to chemically deactivate of NDB only at the outer leaflet of 
the bilayer and obtain asymmetrically NBD-labelled POPC liposomes. The decrease of 
NBD fluorescence occurring in the result of quenching of NBD by dithionite was 
monitored at the excitation of 463 nm and emission at 530 nm. The dithionite quenching 
led to the reduction of about 60–65% of NBD fluorescence signal corresponding to the 
quenching of NBD at the outer leaflet of the bilayer. Next, POPC solution was passed 
through a G-10 sephadex (Sigma-Aldrich) fast spin column to remove the excess of 
dithionite. Asymmetrically labelled POPC liposomes were incubated with peptides at 
concentrations indicated above, and FRET from tryptophan residues to NBD at the inner 
leaflet of bilayer was monitored at 280 nm excitation wavelength, and emission was 
recorded from 310 to 580 nm. 
Cell Lines. Human cervix adenocarcinoma (HeLa) cells were acquired from the American 
Type Culture Collection. Cells were cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM) supplemented with 10% fetal bovine serum (FBS), 10 μg/mL of ciprofloxacin in 
a humidified atmosphere of 5% CO2 and 95% air at 37 °C. 
Cytotoxic Assay. HeLa cells were loaded in the wells of 96-well plates (~5,000 cells per 
well) and incubated overnight. Growth medium was replaced with the medium without 
FBS pH 6.2 or pH 7.4 containing increasing amounts of constructs (5, 10, 20, and 40 μM). 
The same volume of DMEM medium supplemented with 20% FBS, pH 7.4 was added 
after 2 hours of treatment. After 48 hours of incubation a colorimetric reagent (CellTiter 
96 AQueous One Solution Assay, Promega) was added for 1 hour followed by measuring 
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absorbance at 490 nm to assess cell viability. All samples were prepared in triplicate. 
Proliferation Assay. HeLa cells were loaded in the wells of 96-well plates (~5,000 cells 
per well) and incubated overnight. Growth medium was replaced with the medium without 
FBS pH 6.0 or pH 7.4 containing increasing amounts of peptide-amanitin construct (0.5, 
1, 2, and 4 μM). The construct was removed from cells after 3 hours. After 48 hours of cell 
incubation in standard growth medium, a colorimetric reagent (Cell Titer 96 AQueous One 
Solution Assay, Promega) was added for 1 hour followed by measurements of absorbance 
at 490 nm to assess cell viability. All samples were prepared in triplicate. 
Fluorescent Microscopy.  HeLa cells (8,000 cells per dish) were seeded in the center of a 
35-mm dish with a 10-mm glass-bottom window coated with collagen (MatTek Corp). 
Next day cells were incubated with 5 μM of FITC-labelled c[E4W5C] peptide for 30 min 
in DMEM medium without FBS at pH 7.4 or 6.2. Cells were washed 5 times at pH 7.4 and 
0.4% Trypan Blue was added for 5 min (1/10 of the total volume). Fluorescent images were 
acquired with a Retiga CCD camera (Qimaging) mounted to an inverted Olympus IX71 
microscope (Olympus America, Inc.). 
Cellular uptake. HeLa cells (150,000 cells per sample of total volume of 500 μL) were 
incubated with 5 μM of Alexa546-labelled peptide in Leibovitz’s (L15) medium at pH 6.2 
and 7.4 in the presence or absence of 4% of fetal bovine serum (FBS) for 6 hours, followed 
by extensive washing with L15 medium. The cellular uptake of the constructs was 
measured by fluorescent signal from cells counted using cellometer (Cellometer Vision 
CBA, Nexcelom). 4% of FBS was used to mimic the amount of albumin in whole blood, 
which contains 45% of red blood cells, white blood cells and platelets suspended in plasma 
(about 55% of volume). Plasma is composed of about 92% of water, 1% of vitamins, 
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sugars, salts, minerals, hormones and 7% of vital proteins including albumin, gamma 
globulins and other clotting factor. Thus, the amount of albumin in whole blood is expected 
to be less than 3.6%. 
Ex Vivo Fluorescence Imaging. All animal studies were conducted according to the 
animal protocol AN04-12-011 approved by the Institutional Animal Care and Use 
Committee at the University of Rhode Island, in compliance with the principles and 
procedures outlined by NIH for the Care and Use of Animals. 4T1 breast tumors were 
established by subcutaneous injection of 4T1 cells (8 × 105 cells/0.1 mL/flank) in the right 
flank of adult female BALB/c mice (about 19–22 g weight) obtained from Harlan 
Laboratories. When tumors reached about 6 mm in diameter single tail vein injections of 
100 μl of 40 μM Alexa546-peptides were performed. Control mice bearing tumor used to 
establish an auto fluorescence signal did not receive fluorescent peptides. At 4 hours post-
injection euthanization and necropsy was performed followed by ex vivo imaging of tumor, 
kidneys, liver, lungs and muscle. Mean fluorescence intensity of tumor and organs was 
calculated using Kodak software. 
Statistical analysis. Statistically significant differences were determined by two-tailed 
unpaired Student’s t-test (p-level < 0.05 was taken as significant). 
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Figure 1: Chemical structures of six cyclic and one linear peptides containing tryptophan 







Figure 2: The changes of tryptophan fluorescence are used to follow the partition of the 
peptides into POPC liposomes as a function of pH. 






Figure 3: Quenching of fluorescence of peptides in the presence of POPC liposomes at pH 
8 (blue lines) or at pH 3 (red lines) by acrylamide (green lines) and 10-DN (magenta lines) 
are shown. 






Figure 4: NBD fluorescence spectra of peptides in phosphate buffer at pH 8 (black lines) 
and in presence of asymmetrically labelled POPC liposomes containing NBD at the inner 
leaflet at pH 8 (blue lines) and at pH 3 (red lines) are shown. 
The numbers indicate an increase of FRET at pH 3 compared to the peptide fluorescence 






Figure 5 (a–c) Concentration- and pH-dependent inhibition of HeLa cells proliferation was 
monitored at 48 hours after incubation of cells within (a) cleavable c[(WE)4WC]-S-S-
amanitin, (b) cleavable c[E4W5C]-S-S-amanitin and (c) non-cleavable c[E4W5C]-amanitin 
constructs for 3 hours at normal (pH 7.4) and low (pH 6.0) pHs followed by constructs 
removal and keeping cells in DMEM with 10% FBS at pH 7.4. (d) HeLa cells were treated 
with FITC-labelled c[E4W5C] peptide conjugate (5 μM) for 30 min at pH 7.4 or 6.2, 
followed by washing at pH 7.4 in both cases, addition of Trypan Blue for 5 min and live 
cell imaging. (e) Cellular uptake of Alexa546-labelled c[E4W5C] peptide conjugates (5 
μM) treated with HeLa cells for 6 hours in L-15 media at pH 6.2 in absence and presence 
of 4% of FBS, followed by washing and counting of fluorescent signal from cells using 
cellometer. Data are presented as mean ± St.D. The two-tailed unpaired Student’s t-test was 





Figure 6: Ex vivo fluorescence imaging of tumor, muscle, lungs, liver and kidneys 
collected at 4 hours after intravenous administration of Alexa546-peptides are shown. 





Figure 7: Ex vivo fluorescence imaging of tumor, muscle, lungs, liver and kidneys 
collected at various time points after intravenous administration of Alexa546 
asymmetric c[E4W5C] (a) and c[R4W5C] (b) peptides; (c) Tumor/organ ratios calculated 






Figure 8: The cyclic peptide molecules distribution between outer and inner leaflets of the 
lipid bilayer of plasma membrane. 
At neutral and high pHs, Glu residues are negatively-charged (red circles). Trp residues 
(green circles) interact with polar headgroups. Cys residue (yellow circle) could be directed 
into bilayer or away depending on cargo hydrophobicity conjugated with Cys. The majority 
of cyclic peptides could be found on the outer bilayer of plasma membrane of normal cells 
compared to the inner bilayer due to the small pH gradient (pHe = 7.4 and pHi = 7.2). A 
drop of a pH leads to the protonation of Glu residues (blue circles), which enhances 
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The pH (low) insertion peptide (pHLIP) is a family of peptides that are able to insert into a 
lipid bilayer at acidic pH. The molecular mechanism of pHLIPs insertion, folding and 
stability in the membrane at low pH is based on multiple protonation events, which are 
challenging to study at molecular level. More specifically, the relation between the 
experimental pK of insertion (pKexp) of pHLIPs and the pKa of the key residues is yet to be 
clarified. We carried out a computational study, complemented with new experimental data, 
and established the influence of (de)protonation of key titrable residues on the stability of 
the peptide membrane-inserted state. Constant-pH molecular dynamics simulations were 
employed to calculate the pKa values of these residues along the membrane normal. In the 
wt-pHLIP, we identified Asp14 as the key residue for the stability of the membrane-inserted 
state, and its pKa value is strongly correlated with the experimental pK
exp measured in 
thermodynamics studies. Also, in order to narrow down the pH range at which pHLIP is 
stable in the membrane, we designed a new pHLIP variant, L16H, where Leu in the 16th 
position was replaced by a titrable His residue. Our results showed that the L16H variant 
undergoes two transitions. The calculated pKa and experimentally observed pK
exp values are 
in good agreement.  Two distinct pKexp values delimit a pH range where the L16H peptide 
is stably inserted in the membrane while, outside this range, the membrane-inserted state 
is destabilized and the peptide exits from the bilayer. pHLIP peptides have been 
successfully used to target cancer cells for the delivery of diagnostics and therapeutic 
agents to acidic tumors. The fine tuning of the stability of pHLIP inserted state and its 
restriction to a narrow well-defined pH range might allow the design of new pHLIPs, able 
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The pH (low) insertion peptides (pHLIP) is a family of peptides that insert into 
lipid bilayers at low pH.1–8 The original version of this peptide was  derived from a 
transmembrane C  helix of bacteriorhodopsin.1 Biophysical studies revealed three 
major states of pHLIPs (see Figure 1 in Ref. 9): (State I) when the peptide is in solution 
and does not adopt a defined structure; (State II) in the presence of a membrane at 
neutral or high pH the peptide is mostly unstructured yet adsorbed to the bilayer surface 
(pHLIPs with different sequences adopt different configurations in this state10,11); 
finally  (State  III), by  lowering  pH,  the key residues protonate, leading to an increase 
of the peptide hydrophobicity and insertion across the membrane to form a stable 
transmembrane (TM) α-helix.3 This behaviour from pHLIP peptides is significantly 
different from other typical transmembrane peptides, such  as the WALP/KALP 
peptide family.12–16 In this case, the high membrane affinities are pH-independent 
and lead to inserted transmembrane helical structures, even when ionized residues are 
introduced in the middle of the WALP sequence.16,17  
pHLIP sequences share common features: a TM region, with hydrophobic 
residues and one or more acids (Asp or Glu), and N- and C-terminus flanking 
sequences.  Both flanking sequences have several charged residues, which are essential 
for peptide solubility. In most pHLIPs, C-terminus flanking sequences are transient 
membrane inserting segments18), which contain a variable number of anionic groups, 
affecting the rate of pHLIP insertion withdrawal from the bilayer.5 The TM sequence 
(WARYA14DWLFTTPLLLL25DLALLV) of wild- type (wt) pHLIP contains many 
hydrophobic residues (including two Trp residues, which are used to monitor the 
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propagation of the peptide into the lipid bilayer) and two Asp residues at positions 14 
and 25. These titrable residues play an essential role in both the pH-dependent insertion 
of pHLIP into the lipid bilayer and the stability of the membrane-inserted state, since 
they must be protonated (at least partially) for insertion process to occur.19 
Thermodynamics studies of Trp fluorescence changes in pHLIP with pH on 
liposomes allow to investigate the stability of the membrane-inserted state at different 
pH values, which is typically presented by a pK of the peptide insertion (pKins – onward 
referred as pKexp).  This pK value is expected to be related with the pKa of one or both 
Asp residues at the mem- brane/water interface. In fact, the pKexp of the wt-pHLIP is 
6.0,20 which is the expected value for Asp at the interface.21 Moreover, pHLIP peptides 
with single mutations D14E or D25E (Asp− >Glu) show an increase in the pKexp of ∼ 
0.5 pK units,20 which is approximately the difference in the pKa values between Asp 
and Glu in solution.  This suggests that the pKa values of these acids are strongly related 
with pKexp. The effect of shifting Asp14 to the 13th or 15th positions which, in 
principle, changes the solvent exposure of this residue, has also been studied.22 These 
results, where the pKexp decrease is concomitant with an increase of solvent exposure 
(13th position) and vice versa,22 suggest a crucial role of Asp14 in the stability of the 
membrane-inserted state.  
A typical pHLIP variant has a single value of pKexp: a pH below which more 
than 50% of the peptide population is inserted in the bilayer. Since acidosis is a 
universal marker for tumor identification, the pH-sensitive interaction of pHLIPs with 
the cell membrane renders it a good transport system for tumor targeting, delivering 
drugs and imaging agents to cancer cells. pHLIP can target and accumulate in tissues 
with the extracellular pH below pKexp, usually cancer cells in tumors, but also naturally 
acidic organs, such as kidneys and stomach (in the case of oral administration).20,23,24 
It would be advantageous to control the stability of pHLIP’s inserted state and restrict 
it to a narrow well-defined pH range. Cationic residues, when protonated (charged), 
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have been shown to hinder pHLIP membrane insertion.23 A histidine residue, when 
inserted in a lipid bilayer, has its pKa value shifted below the pKa of aspartic acid,
21 
leading to a protonation event (generation of a positive charge), which could 
destabilize the membrane-inserted state and induce the peptide withdrawal from the 
membrane. In theory, it is required a large enough difference between the His and Asp 
pKa values to generate a significant population of the inserted peptide (where His and 
Asp are in their neutral forms), but narrow enough to allow the peptide to discriminate 
between organs/tumors with slightly different acidities. 
The investigation of the protonation states of the titrable residues in pHLIPs is 
an essential step to understand the molecular mechanism of pHLIP action and might 
open an opportunity to design new peptide variants with desirable targeting properties. 
Computational approaches are well suited to address this challenge. In particular, 
molecular dynamics (MD) simulations have been used to investigate the membrane 
insertion mechanism25,26 and the stability of pHLIP.27 However, in classical MD 
simulations all protonation states are fixed, which means that pH is not explicitly 
modeled. Constant-pH molecular dynamics (CpHMD) methods21,28–51 have been 
developed over the years to allow the inclusion of pH effects in MD simulations. In 
the stochastic titration method, the Poisson–Boltzmann estimated energies are used in 
Monte-Carlo calculations to obtain protonation states that are representative of the 
system conformation/configuration. The use of continuum electrostatics to obtain the 
free energies of changing protonation states has been successfully adopted by many 
methods,21,30–45 while offering the important advantage of computational speed.  We 
have extended the stochastic titration method30,34 to include lipid bilayers (CpHMD- 
L)43,44 in order to study the protonation profiles of peptides and proteins interacting 
with lipid bilayers.21 This methodology was recently used to calculate the pKa values 
of individual titrable amino acids when inserting in a lipid bilayer and showed that, 
despite sampling limitations, it was possible to estimate pKa values at deep inserted 
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positions, right before losing contact with bulk water, hence with the proton buffer.21  
Here, we used our recently developed CpHMD-L method to study the 
protonation profile of all titrable amino acids in pHLIP when inserted in a lipid bilayer 
(State III). These simulations were performed to identify the key residues determining 
the stability of pHLIP in the membrane, which is reflected by the observed 
experimental pKexp. We also proposed a new pHLIP sequence with a histidine located 
near the key Asp14 (L16H pHLIP variant). Computer simulations predicted a second 
protonation event at lower pH values, that experimental results confirmed to be also 




2.1 System setup and CpHMD simulations 
 
In this work, we focused our efforts on the wt sequence of pHLIP24 and L16H variant 
(see Table 1). In the case of L16H variant, we replaced the Leu residue at the 16th 




wt          ACEQNPIYWARYA14DWLFTTPLLLL25DLALLVDADEGT 




a His since, being two positions below Asp14 in a α-helical structure, the two residues 
should point to opposite directions.  The rationale is based on the assumption that these 
residues   do not interact strongly, thus, they should have their pKa values only weakly 
correlated wt and L16H pHLIP sequences were simulated using the stochastic titration 
CpHMD- L method.21,30,34,43,44 The peptides were built inserted in a bilayer of 256 2-
oleoyl-1-palmitoyl- sn-glycero-3-phosphocholine (POPC) lipid molecules and placed 
with Asp14 and Asp25, in their protonated (neutral) forms, equidistant to the 
45 
membrane center. This unbiased configuration was chosen to avoid favouring the 
solvent exposure of one acidic residue over the other. The protonation states of Asp, 
Glu, His, Cys, C-ter and N-ter were allowed to titrate in the pH range of 4.0 to 7.0, 
with a 1.0 pH step. Each CpHMD cycle was 20 ps long (τprt) and each solvent 
relaxation step was 0.2 ps long (τrlx).  At each pH value, three replicates were 
performed for 100 ns. Within this short time scale, the peptides are expected to remain 
inserted in the membrane which allows us to characterize the pH effects on the 
membrane- inserted state of pHLIP (State III). The first 20 ns were disregarded in the 
analyses to allow for system equilibration. 
2.2 Molecular dynamics settings 
All molecular dynamics simulations were performed with the GROMOS 54A7 force 
field52 using a modified version34 of GROMACS 4.0.7.53 A twin-range scheme was 
used with short- and long-range cutoffs of 8 and 14 A˚, respectively, with neighbor lists 
between the two cutoff values being updated every 5 steps. Long-range electrostatic 
interactions were treated with the generalized reaction field (RF) method.54 Although 
the RF method is not optimal to capture the long range electrostatics of membrane 
systems, due to its anisotropic nature, there are several advantages in its use within the 
CpHMD framework, namely the high computation speed and its consistency with the 
recent GROMOS force fields (including lipid parameters),55 where all parametrization 
and validation were performed with this method. Recently, it has been shown that the 
system net charge can introduce systematic errors in pKa values obtained with a λ-
dynamics based CpHMD method.56 However, with our CpHMD method, which uses 
GRF and an implicit ionic strength in the protonation calculations (see below), we have 
not observed such effects. 34,45 The RF dielectric constant used was 5 4 5 7  a n d  an 
ionic strength of 0.1 M was also employed. The lipid and protein bond lengths were 
constrained using the P-LINCS algorithm, 58 while the SETTLE algorithm59 was used 
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for water molecules (simple point charge, SPC60). Newton equations of motion were 
integrated using a time step of 2 fs keeping constant the number of molecules, the 
pressure, and the 
temperature (NPT ensemble).  The temperature of the systems was separately coupled 
to     a v-rescale61 temperature bath at 310 K and relaxation times of 0.1 ps. A semi-
isotropic Parrinello-Rahman pressure coupling62 was used at 1 bar with a relaxation 
time of 5 ps and 
a compressibility of 4.5 × 10−5 bar−1. 
 
2.3 Poisson-Boltzmann/Monte-Carlo calculations 
The Poisson–Boltzmann (PB) calculations were performed using the program DelPhi 
V5.1, 63 using partial charges from the GROMOS 54A7 and radii obtained from the 
Lennard-Jones parameters of this force field. These calculations were performed on 
the fully atomistic pHLIP/POPC system. The molecular surface of the solute (here the 
solute can be seen as the membrane + peptide supramolecular complex) was defined 
using a probe of radius 1.4 A˚, the ion exclusion layer was 2.0 A˚, and the ionic strength 
was 0.1 M. A dielectric constant of 2 was used for the solute and 80 for the solvent. A 
twostep focusing procedure was used with grid spacing of approximately 1 and 0.25 
A˚ in the large and small grids, respectively (corresponding to 91 grid points). In the 
coarse grid, relaxation parameters of 0.20 and 0.75 were used in the linear and 
nonlinear iterations processes and periodic boundary conditions were applied in the x 
and y directions. The background interactions were calculated up to 25 A˚ and the 
convergence threshold for the electrostatic potential was set to 0.01.  
The PB-derived free energy terms were then used to sample protonation states within 
a Monte Carlo (MC) scheme performed using the PETIT program.64 Proton 
tautomerism was taken into account in all titrable groups. ×105 MC cycles were 
performed for each conformation where a cycle corresponds to a trial change of each 
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individual site.  
2.4 pKa calculation along the membrane normal 
To calculate the residues pKa values along the membrane normal, we split our 
conformations according to their relative depth to the average position of membrane 
“P” atoms within a 6 A˚ radius from pHLIP. This method describes better the local 
deformations induced by the peptide, since it only uses neighboring “P” atoms to 
obtain the reference average position. 
After sorting the conformations in 1 A˚ insertion slices, we separate them by 
protonation states of the group of interest.  Here, we apply a minimum criteria of 50 
frames in at least 2 pH values in order to be able to calculate the pKa values and estimate 
their standard errors. The protonation states in each slice are used in a Hill fitting 
procedure to obtain the respective pKa value. 
Assuming that a peptide stability in the membrane is regulated by the 
protonation of a single titrable residue, then the most inserted pKa value of this residue 
can be regarded as our “in silico” estimation of the experimentally measured 
thermodynamic parameter, pKexp. The rationale is that, upon membrane insertion, this 
pKmemb value, at the last moment while the group is still in contact with solvent and 
senses the pH value, will define the peptide stability in the membrane-inserted state. 
 
2.4 Analyses and error calculations 
The thickness of membrane bilayers is often calculated as the distance between the 
average Z coordinate of the “P” atoms for each monolayer. However, the presence of 
a peptide may induce local membrane deformations, which will affect these 
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calculations. To circumvent these issues and to quantify membrane perturbations, we 
developed a method that calculates monolayer thickness values, for different annulus 
regions in the xy plane moving radially away from the peptide. First, we define an 
unaffected region, loosely called “bulk”, which (in our simulations) corresponds to 
all “P” atoms beyond a 15 A˚ radius from pHLIP. The membrane center is then 
calculated using only these bulk phosphate atoms as reference.  The membrane center 
allows the splitting of the peptide atoms between the two monolayers, which can now 
be used in two separate thickness calculations. Moving a sliding annulus (by 
increasingly changing its radii) away from the peptide in the xy plane (2 dimensions), 
we calculate the distance between the average “P” atoms (contained in the annulus) Z 
position and the membrane center. This procedure is applied to all snapshots of our 
simulations and, at longer radii, both monolayer thickness values should converge to 
a “bulk” value, i.e. half the thickness value for pure POPC. 
All error values shown in the pKa profile plots were obtained using a modified jackknife 
resampling method. We generated 5 sub-set combinations of our total sampling by 
using only 4 out of 5 replicates (1234, 1235, 1245, 1345, and 2345). We used these 
combinations for the slicing and Hill fitting procedure. The final standard errors were 














In the equation, n  is the number of simulation replicates,  x¯ is the predicted pKa  value 
and xi is the pKa value obtained in each i combination of replicates. We also apply 
the previous criteria to the pKa values calculation, namely, each i sub-set requires 
at least 50 frames for each protonation state and a minimum of two different pH 
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values. Note that this standard error calculation procedure introduces a new 
restriction criterion to the final pKa profile plots, where all protonation/insertion 
values need to be originated from more than 
one replicate. Finally, all error values above 2 pK units were excluded. 
 
2.6 Synthesis of pHLIP 
The L16H pHLIP variant was produced by solid-phase synthesis and purified by CS 
BioCo., and was characterized by reversed-phase high performance liquid 
chromatography (RT- HPLC) using Zorbax SB-C18 and Zorbax SB-C8, 4.6 × 250 mm 
5µm columns (Agilent Technologies). Peptide solution concentrations were determined 
using absorbance at 280 nm, where c280 = 13940 M
−1 cm−1. 
 
2.7 Liposome preparation 
Small unilamellar vesicles were used as model membranes and were prepared via thin film 
formation, rehydration, and extrusion. A thin lipid film was prepared by dissolving 1- 
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC; Avanti Polar Lipids) in 
chloroform at a concentration of 33 mg mL−1,  then  desolvated  using  rotary  evaporation  
and  placed  under vacuum for 2 hours. The resulting thin POPC film was rehydrated using 
2 mM citrate-phosphate buffer at pH 8.  Finally, the liposome solution was vortexed and 
extruded 21 times through a membrane with a pore size of 50 nm. 
2.8 pH dependence measurements 
 
The pH dependence measurements were carried out by monitoring the shift of the 
position of maximum of peptide fluorescence as a characteristic of changes of the 
peptide environment by varying pH. Peptide fluorescence spectra were measured using 
a PC1 spectrofluorometer (ISS) with temperature control set to 25.0 ◦C. Tryptophan 
residues were excited using an excitation wavelength of 295 nm. Both excitation and 
emission slits were set to 4 nm widths; excitation and emission polarizers were set to 
54.7◦ (magic angle) and 0.0◦, respectively. Samples were prepared 24 hours prior to 
50 
running experiments to allow for equilibration in State II. 
The pH of solutions containing 7 µM peptide and 1.4 mM POPC was lowered 
using citric acid and measured using an Orion PerHecT ROSS Combination pH Micro 
Electrode and an Orion Dual Star pH and ISE Benchtop Meter (Thermo Fisher 
Scientific) before and after spectrum measurement to ensure equilibration. At each pH, 
the tryptophan fluorescence spectrum was recorded, and the spectra were analyzed 
using the Protein Fluorescence and Structural Toolkit (PFAST) to determine the 
positions of spectral maxima.18 The obtained 
positions of spectral maxima were plotted as a function of pH. The pH-dependence 
curve was fit using Levenberg Marquardt iteration algorithm of the bi-dose response 
module in Origin 2017 to determine parameters of cooperativity and mid-point of the 
transitions. 
 
2.9 Oriented circular dichroism measurements 
Oriented circular dichroism (OCD) measurements were performed on an MOS-450 
spectrometer (Bio-Logic Science Instruments) in the range of 190 to 260 nm with a 
step size of 1 nm, and with temperature control set to 25.0 ◦C. OCD was conducted 
using supported planar POPC bilayers prepared using a Langmuir-Blodgett system 
(KSV Nima). Fourteen quartz slides with 0.2 mm spacers were used; after sonicating 
the slides in 5% cuvette cleaner (Con- trad 70; Decon Labs) in deionized water (≥ 18.2 
MΩ cm at 25 ◦C; Milli-Q Type 1 Ultrapure Water System, EMD Millipore) for fifteen 
minutes, then rinsing with deionized water, the slides were immersed and sonicated 
for ten minutes in 2-propanol, sonicated again for ten minutes in acetone, sonicated 
once more in 2-propanol for ten minutes, and rinsed carefully with deionized water.   
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Lastly, the slides were immersed in a 3:1 solution of sulfuric acid   to hydrogen 
peroxide for five minutes and rinsed thoroughly deionized water. The slides were 
stored in deionized water until they were used. POPC bilayers were deposited on the 
fourteen slides using a Langmuir-Blodgett minitrough: a 2.5 mg mL−1 solution of 
POPC in chloroform was spread on the subphase (deionized water) and fifteen minutes 
was allotted for the evaporation of the chloroform, after which the POPC monolayer 
was compressed to 32 mN m−1. A lipid monolayer was deposited on the slides by 
drawing them from the sub- phase, after which a solution of 10 µM peptide and 500 
µM of 50 nm POPC liposomes at pH 4 was added to the slides, producing supported 
bilayer by fusion between the monolayer on the slides and the peptide-laden lipid 
vesicles. After incubation for six hours at 100% humid- ity, the slides were rinsed with 
buffer solution to remove residual liposomes, and the spaces between the cuvettes were 
filled with buffer of appropriate pH. Measurements were taken at three points during 
the experiment:  directly after the addition of the peptide/lipid solution (0 h), after the 
slides were rinsed to remove excess liposomes after the six-hour incubation time (6 
h), and after an additional twelve-hour incubation time and rinse with buffer (18 h); 
these measurements were recorded on the MOS-450 spectrometer with sampling times 
of 1 second at each wavelength. 
 
 
3 RESULTS AND DISCUSSION 
3.1 Molecular details of membrane inserted pHLIP 
 
The main goal of our work is to elucidate the role of titrable residues in the stability of 
wt-pHLIP membrane-inserted state (State III). Our calculations should correlate with 
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the equilibrium biophysical studies on liposomes, where pH outside and inside of a 
liposome equilibrates quickly and is considered to be the same at both sides of a lipid 
bilayer. 65 We carried out simulations, at different pH values (4.0–7.0), with the peptide 
inserted in a POPC lipid bilayer. Within the time scale of our simulations (100 ns), 
the peptide is expected to remain stable in the membrane-inserted state (the withdrawal 
process occurs in a much larger time scale65), which allow us to characterize the effect 
of pH on the membrane-inserted state. There is a multitude of experimental data 
regarding the characterization of pHLIP in- serted in lipid bilayers.1–8,65 In particular, 
the original transmembrane region (residues 9– 3066) has often been assumed to be 
conserved with Asp14 and Asp25 inserted in the lipid bilayer. Although, the helical 
content is conserved in the membrane-inserted state at all sim- ulated pH values (Figure 
S1 in Supporting Information), the overall preferred position of the peptide is 
significantly shifted towards the N-terminus monolayer (Figure 1 and Figure S2). At 
all pH values, the peptide bends at the membrane/water interface, consistently losing 
helical content around residues 15–18. Interestingly, the proline residue at the 20th 
position is not directly involved in this loss of secondary structure. The presence of 
Arg11 in the N-terminus domain, close to the interface, and the presence of two 
segments of hydrophobic residues, 21-24 and 26-30, seem to be the main factors 
determining both the position and orientation of wt-pHLIP in the lipid bilayer. At pH 
6.0, which is the experimentally observed pKexp, Asp25 is preferably located at the 
bilayer center, thus not exchanging protons with water. Concomitantly, Asp14 is only 
partially inserted in the membrane, singling it out as the key proton active residue. 
Interestingly, the peptide N-terminus is interchanging between the water phase and the 
water/membrane interface, suggesting that residues 1–13 are either solvated or 
adsorbed to the membrane. Varying pH leads to slightly different preferred positions 
for the transmembrane region of pHLIP, where the ionization of Asp14 seems to be 
the driving factor for the destabilization of the membrane-inserted state. Nevertheless, 
53 
even at lower pH values, Asp14 is always able to reach water accessible regions and 
sense the pH value. At the C-terminus, we observe that the four acidic groups (Asp31, 
Asp33, Glu34, and C-ter) are also titrating and their preferred positions relative to the 
membrane center seem to be a consequence of their topological order and ionization 
states. At high pH values, when these residues are mostly ionized, they are not deeply 
inserted as Figure S2 suggests, but rather induce a significant local deformation on the 
closer monolayer. In fact, the mono- layer thickness profiles around pHLIP show a 
clear local depression in the C-terminus side (Figure 2). A small bilayer deformation 
(¡10 %) occurs at pH < 7.0, however, a larger effect is observed at pH 7.0 (∼20 % – 
Figure S3 in Supporting Information), since, at this pH value, the more stable 
thermodynamic state is not the fully inserted (State III) but rather   the membrane-
adsorbed (State II). In both cases, the observed deformations are only local being 
completely dissipated at ∼30 ˚A  radially  away from  the  peptide.  At the N-terminus 
side, there is only a small membrane perturbation almost within the error bars. Also, 
beyond 
∼15 A˚ from the peptide, both monolayers thicknesses reach a plateau and the sum of 
their values correspond roughly to the experimental POPC thickness (36.5 A˚).67 
3.2 pKa profile of Asp14 
 
We  calculated the pKa  values  of Asp14 using average protonation values obtained 
from the constant-pH molecular dynamics simulations (CpHMD-L). This method 
allows for the titrable residues to update their protonation states depending on the 
pH and their microenvironment. Hence, it is possible to measure the proton affinity of 
a given group along the membrane normal. Indeed, we  have  previously observed that 
aspartic acid,  in the middle  of a capped alanine pentapeptide (AADAA), has its pKa 
value shifted when inserting in a lipid bilayer, favoring its neutral form.21 The pKa 
values, varying with the level of residue insertion into the membrane,  can be called 
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pKa  profiles.  A key feature of this method is a good estimation of the depth of insertion 
of a particular residue, which correlates with its solvent exposure, taking into 
consideration the membrane local deformation. In a pKa profile, the value calculated 
at the deepest membrane-inserted location of a residue, the pKa value at the limit of our 
sampling, could be considered as an estimation of the pKmemb. It should correspond to 
a region of scarce solvent exposure, when the residue does not exchange protons with 
water anymore, and it is no longer able to sense pH. If we know which residue is 
responsible for the stability of the peptide membrane-inserted state,  then its pKmemb   
value is our estimation of the experimental pKexp. The pKa profile of Asp14 shows 
significant shift along the membrane normal, reaching a pKmemb value of 6.0±0.1, 
at the deepest membrane inserted position (Figure 3A), which is in excellent 
agreement with the experimentally observed pKexp value (6.024). 
The C-terminus region of pHLIP has five carboxylic acids, including Asp25.   
In the membrane-inserted configuration, Asp31, Asp33, Glu34 and C-ter are accessing 
the solvent on the other side of the bilayer, opposite to Asp14. Therefore, in this 
configuration, their pKa profiles are only related to the exit pathway insertion process 
of pHLIP, the protonation order of these acidic residues, is most likely related to their 
topological position in the peptide sequence (Figure 1). Furthermore, their pKa values 
have contributions from the desolvation effects21 and the electrostatic repulsion 
between the negatively charged residues.  Hence, the observed trend in the pKa profiles 
is in agreement with the expected for an anionic group (Figure 3B). The protonation 
(charge neutralization) of each residue, reduces the local negative potential, decreasing 
the pKa shift of the remaining residues when they reach similar (despite its lack of 
sampling) because, at this point, all other carboxylic groups are ionized. On the 
contrary, C-terminus exhibits a small pKa shift, since it is measured in the absence of 
other negative charges. Along these lines, Asp25 would show an even higher pKmemb 
value, but not enough (de)protonation events were observed in our simulations, 
precluding an accurate pKa calculation. 
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pHLIP is in equilibrium between the membrane membrane-inserted states and 
the experimental pKexp value  is an average of these populations ratio.  According to 
our results, the occurrence of the membrane-inserted state requires complete 
protonation of both Asp25 and Asp14, even though the stability of this state is 
regulated only by the (de)protonation of Asp14, which is able to exchange protons with 
water. The double pro- tonation is in agreement with isothermal calorimetry (ITC) 
data, which estimates that 1.8 protons are required for the insertion process.19 The 
four carboxylic acids at the C-terminus domain are at the water/membrane interface 
in both end states, hence, their pKa values should not have a direct effect on the 
equilibrium populations. However, the membrane crossing energetic barrier for a 
charged group is usually unsurmountable.68,69 Therefore, in the kinetic process of the 
peptide insertion (or exit) into (from) the membrane, all acidic residues in the C-
terminus region would need to, at least transiently, protonate. To obtain a fully neutral 
C-terminus domain, the acidic groups will likely become neutral sequentially, 
following their topological order. Hence, these protonations can be slow, depending 
on the number of anionic residues and their pKmemb values. This is in agreement with 
the experi- mentally observed slow kinetics for wt-pHLIP, when compared with other 
variants with fewer acidic residues in the aforementioned region.24 
 
3.3 The L16H variant shows two pKexp values 
 
The ionization of residues in pHLIP TM region induces a transition between State 
III and II. In the wt-pHLIP variant, Asp14 preferentially ionizes at pH values larger 
than 6.0, which leads to the destabilization of the membrane-inserted state and 
peptide exit from the 
. However, below pH 6.0 the peptide membrane-inserted state is well stabilized. By 
introducing a cationic residue (such as histidine) we observe the opposite effect, i.e. 
the peptide withdrawal from the membrane now occurs at lower pH values when the 
residue is ionized.70 Hence, with a combination of these two strategies, we can design 
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a peptide with 
two transitions, each having its own pKexp value. In this case, provided that the 
pKmemb 
of the cationic group is lower than that of the anionic, the peptide will be stabilized in 
its membrane-inserted state in the pH range within the two pKmemb values (Figure 4). 
To test this hypothesis, we designed the L16H pHLIP variant, where the cationic 
residue (His16)  is deeply inserted in the membrane and facing an opposite direction 
from Asp14. We have performed CpHMD simulations with this variant and calculated 
the corresponding pKa val- ues (Figure 5). The obtained profiles are similar to the 
observed for pentapeptides inserting into a lipid bilayer.21 The pKa value of His16 
(Asp14) decreases (increases) with insertion into the membrane, since the membrane 
stabilizes their neutral forms. Although the profile of Asp14 is similar to wt-pHLIP, 
we observe a pKa increase in the membrane-inserted state. This suggests that the 
histidine residue slightly alters Asp14 microenvironment upon insertion (even though 
the conformational properties are not significantly altered - Figure S5 and S6 in 
Supporting Information). The two pKa profiles show that the L16H peptide has two 
pKmemb values (6.8 ± 0.2 for Asp14 and 4.7 ± 0.3 - or ∼3.1 without error bars - for 
His16), thus the peptide is expected to be stabilized in the membrane-inserted state 
only within the 3.1–6.8 pH range.  
The L16H pHLIP variant was synthesized and its interaction with POPC 
liposomes was studied employing spectroscopic techniques. The pH-dependence of 
L16H pHLIP variant was observed by measuring the shift in the peptide fluorescence 
spectra maximum between pH 1.5 and 8.5 (Figure 6A). The position of the maximum 
of the emission spectra mainly reflects the solvent exposure of the tryptophan residues, 
hence, providing information on the degree of the membrane penetration. The data 
were fitted assuming two transitions and confirm  the existence of two pKexp  in L16H 
pHLIP variant  (5.9 and 3.3),  which can be attributed  to the pKmemb values of Asp14 
and His16, respectively. To identify conformational states of L16H pHLIP at pH 2, 4 
and 8 we measured OCD spectra (Figure 6B). At pH 8 no helical structure was 
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observed, while at pH 4 the transmembrane orientation of helix was confirmed. When 
pH was lowered to 2, the peptide helical content is still preserved. However, contrarily 
to the observed at pH 4, a surface helical orientation is predominant. Overall, the 
obtained results support the two-pKmemb insertion mechanism (Figure 4). Below the 
lowest pKexp, the His residue in the TM region becomes positively charged, while at a 
pH value above the highest pKexp, the Asp residue becomes negatively charged. In both 
cases, it leads to the destabilization of the peptide membrane-inserted state and peptide 
exit from the bilayer. This inserted state is only stabilized in the pH range between 
the two pKexp values. 
Despite on the fact that the membrane-inserted pH range is too wide to be useful 
for 
practical applications, the obtained results should be regarded as a proof-of-concept. 
Hence, they can prompt the design of new pHLIP sequences, with different cationic 
residues, that might narrow down the pKexp range to ∼1 pH unit, so pHLIP might be 





In this work, we studied the protonation profile of all titrable amino acids in pHLIP 
when inserted in a lipid bilayer, and identified Asp14 as the key residue to act as a 
sensor of     the extracellular pH in the membrane-inserted state. The peptide adopts a 
preferential position in the membrane such that Asp25 remains mainly at the bilayer 
center, away from water and unable to sense the pH value, i.e. it is not able to 
exchange protons with the solvent. The pKmemb value calculated for Asp14 in wt-
pHLIP is in excellent agreement with the experimentally measured pKexp.  Our 
simulations also helped to understand the role of the acidic residues at the C-terminus 
flanking sequence. These residues need to be fully protonated to allow the transition 
of pHLIP from the membrane-adsorbed (State II)     to the membrane-inserted (State 
III) conformation. Consequently, the number of anionic groups can have a direct 
influence on the kinetics of the peptide insertion process, as already observed 
experimentally.24,65 
The information obtained at the molecular level helped to understand the peptide 
stability in the membrane and will also give important hints to devise new pHLIP variants 
with specific features.  An example is L16H pHLIP variant, with a histidine residue located 
in the TM region, near Asp14.  Our simulations predicted that this mutation adds a second 
proto-  nation event, at lower pH values, leading to the peptide withdrawal from the 
membrane. The simulations were validated by spectroscopic data indicating the presence 
of two transitions in L16H pHLIP variant. Although this proof-of-concept mutation seems 
to generate a too large range between the two pKexp values, it opens an opportunity for the  
design  of  new variants to achieve fine tuning of pH insertion range, hence increasing the 
potential medical significance of pHLIP technology. 
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In the future, we also plan to use new enhanced sampling strategies coupled with 
CpHMD- L simulations in order to improve the accuracy of these pKa calculations. 
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Figure 1: Probability density of distance to membrane center of key titrable groups in wt- 
pHLIP at pH 6.0 (A). The membrane region is marked as gray with a dashed line at its 
center. For the remaining pH values, see Figure S2 of Supporting Information. 
Representative conformation of membrane-inserted state of wt-pHLIP with the titrable 
groups highlighted (B). Lipid tails are represented as transparent sticks with P atoms as 
grey spheres. pHLIP secondary structure is represented as a dark grey cartoon with key 




Figure 2: Monolayer thickness profiles for wt-pHLIP at pH 6.0. The top monolayer is the 
one interacting with Asp14 and the bottom is the one interacting with the C-terminus acidic 




Figure 3: pKa profile of Asp14 (A) and C-terminus acidic residues (B) along the membrane 
normal obtained with CpHMD simulations of wt-pHLIP. The negative insertion values cor- 
respond to membrane inserted positions, while positive values correspond to more shallow 
locations. The insertion values were measured between the titrable group and the average 




Figure 4: Schematic representation of the pH-dependent mechanism for membrane inser- 




Figure 5: pKa profiles of Asp14 and His16 along the membrane normal obtained with 
CpHMD simulations of L16H pHLIP variant. The unfilled circles in the His16 profile cor- 
respond to a deep inserted region for which we did not have enough sampling to compute  
the error bars. They are shown to qualitatively illustrate the profile tendency. The negative 
insertion values correspond to membrane inserted positions, while positive values 
correspond to more shallow locations. The insertion values were measured between the 
titrable group and the average position of the selected phosphate groups within a 6 ˚A 




Figure 6: pH-dependence of the position of the maximum shift of Trp fluorescence spectra 
of L16H pHLIP variant (A). The experimental data were fitted using the bi-dose response 
module in Origin 2017, to establish cooperativity (n) and mid transition (pKexp). OCD 
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To advance mechanistic understanding of membrane-associated peptide folding and 
insertion, we have studied the kinetics of three single tryptophan pHLIP (pH-Low Insertion 
Peptide) variants, where tryptophan residues are located near the N terminus, near the 
middle, and near the inserting C-terminal end of the pHLIP transmembrane helix. Single-
tryptophan pHLIP variants allowed us probing different parts of the peptide in the pathways 
of peptide insertion into the lipid bilayer (triggered by a pH drop) and peptide exit from the 
bilayer (triggered by a rise in pH). By using pH jumps of different magnitudes, we slowed 
down the processes, and established the intermediates that helped us to understand the 
principles of insertion and exit.  The obtained results should also aid the applications in 
medicine that are now entering the clinic.  
 
SIGNIFICANCE 
The process of peptide insertion across a membrane is of fundamental interest. It also 
illuminates our thinking about the ways that lipid boundaries can interact with the 
molecules they encounter.  Obtained in this study results, combined with our recent  
constant-pH molecular dynamics simulations and kinetics experiments with liposomes of 
different bilayer thicknesses allowed us to complete a generalized model of the insertion 
and folding of polypeptides of the pHLIP family, and   expand the general view of peptide 
conformations and dynamic excursions of the bilayer that can accompany interactions with 
peptides.  While the insertion of pHLIPs across membrane bilayers has basic scientific 
interest, the possibility of clinical applications for tumor imaging and therapy is also 
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emerging as a reality.  By understanding the principles of pHLIP properties, the future 
applications can be broadened and improved.  
 
INTRODUCTION 
pH-Low Insertion Peptides (pHLIPs®1) are being increasingly studied to gain insights 
concerning peptide folding and insertion into membranes, and to apply them in medicine.  
Because their membrane insertion from a water-soluble state is triggered by pH changes, a 
rich opportunity is created for chemical, kinetic and computational studies, as shown by 
the expanding literature from a growing number of laboratories and ongoing efforts to use 
them as medically useful acidity sensors in vivo. Currently, pHLIPs are being used in 
studies of membrane-associated folding and unfolding as a model system (1-10), and in a 
variety of biomedical applications for targeted delivery of imaging and therapeutic agents 
(11-14).  In this paper, we position Tryptophans (Trp) as sensors in the flanking and central 
regions of a pHLIP and exploit kinetic analysis to study the pathways of membrane entry 
and exit. 
Metabolically active cells, like cancer cells and tumor-associated macrophages within 
tumors, or activated macrophages in inflamed tissues, are known to acidify their 
environments (15-18). The extracellular pH in the vicinity of cells in normal healthy tissue 
is about 7.2-7.4, while pH at the surface of cancer cells could be as low as pH 6.0 (19).  
Acidity is a possible biomarker for specific targeting of these cells in diseased tissues, but 
the extracellular pH is only about one pH unit lower than the extracellular pH in healthy 
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organs, creating a challenge for pH-sensitive agents to discriminate between them. A 
family of pHLIPs was designed to have a variety of properties while sharing the 
characteristic pHLIP insertion into membrane lipid bilayers at low pHs (<pH7.0) (11, 20, 
21). A pHLIP’s affinity for a membrane leads to a reversible membrane-adsorbed surface  
state at high and neutral pHs, which allows a pHLIP to sense the pH at the surfaces of cells 
(1), triggering insertion if the pH is low.  Weak surface binding is useful for a pH-sensing 
agent, since the pH at the surfaces of cancer cells is 0.5-0.7 pH units lower than the bulk 
extracellular pH and independent of tumor (tissue) perfusion (19, 22). Another feature of 
the pHLIP delivery system is that these peptides undergo a cooperative coil-helix transition 
in response to a pH change, and the pK and cooperativity of the transition are tunable by 
sequence variation. Further, the activation barrier for insertion into bilayers can be 
adjusted, pre-determining the time required for cellular targeting and insertion (2, 5, 23). 
These parameters have utility for pHLIP applications to real biological systems.  
To advance understanding of the mechanism of the membrane-associated pHLIP folding 
we have extended our kinetics studies of single-Trp pHLIP variants. Observations using 
single-Trp variants have allowed us to observe intermediate steps in the pathways of 
peptide insertion into the lipid bilayer triggered by a pH drop and the peptide exit from the 
bilayer triggered by a rise in pH. 
 
MATERIALS AND METHODS 
pHLIP variants were synthesized and purified by CS Bio Co, and tested for purity by HPLC 
upon receipt. Small unilamellar vesicles were prepared by extrusion. Steady-state 
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fluorescence and circular dichroism (CD) measurements were performed using a PC1 
spectrofluorometer (ISS, Inc) and a MOS-450 spectrometer (Biologic, Inc.), respectively, 
with temperature control set to 25.0°C. Oriented CD (OCD) measurements were conducted 
on the supported bilayers placed on quartz slides using the Langmuir-Blodgett system 
(KSV Nima) as described previously (3). Tryptophan fluorescence and CD kinetics were 
measured using an SFM-300 mixing system (Bio-Logic Science Instruments) connected to 
the MOS-450 spectrometer with temperature control set to 25.0°C. All data were fit to the 
appropriate equations by nonlinear least squares curve fitting procedures employing the 
Levenberg Marquardt algorithm using Origin 8.5. Detailed descriptions of all methods are 
presented in the Supporting Information. 
 
RESULTS 
We studied the kinetics of insertion into and exit from the lipid bilayer of POPC liposomes 
using three single Trp pHLIP variants, with the Trp reporters positioned in each flanking 
region and in the membrane inserted region. pHLIP peptides with a single tryptophan 
residue allow a “clean” photophysical signals originating from single fluorophores, 
avoiding spectral heterogeneity. pHLIP variants were designed based on the closely related 
group of the WT sequences (24), which contains several protonatable residues at the 
membrane inserting C-terminal end of the peptide. As we demonstrated previously, the 
presence of protonatable groups at the C-terminus of the peptide slows down the process 
of insertion of the peptide across a lipid bilayer, as well as slowing exit from the membrane 
(2, 3). These processes are completed within seconds, as opposed to milliseconds for 
truncated pHLIPs (2), which allows resolution of structural details along the insertion and 
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The length of the designed variants is 32 residues and Trp residues are placed at positions 
6, 17 and 30 in the pHLIP sequence in order to be located at the beginning, middle and end 
of the peptide in its helical inserted form. Phe was replacing other two Trp residues in each 
variant, which considered to be the best possible substitution of Trp. Using these designs, 
we can monitor the propagation of different parts of the peptide into and out of the bilayer 
by recording the changes of their fluorescence signals within single-Trp pHLIP variants. 
First, we performed equilibrium measurements presented in Figures 1 and 2. Steady-state 
fluorescence, CD and OCD measurements were used to ensure that each variant is 
responsive to pH and adopts a TM helical orientation in a POPC bilayer at low pH, which 
is the main feature of the peptides of pHLIP family (Supplementary Figure S1). 
Fluorescence spectra were analyzed using the Protein Fluorescence and Structural Tool Kit 
(PFAST) to determine the positions of spectral maxima (λmax) (25, 26). The transition from 
the membrane-adsorbed state at high pH to the membrane-inserted state at low pH was 
assessed from changes of the position of the Trp fluorescence maximum and the ellipticity 
measured at 222 nm in response to a pH drop from 8.5 to 4 (Figure 1 and Table 1). Analysis 
of Trp fluorescence reveals the presence of two transitions, which are especially noticeable 
for the W6 pHLIP variant. The mid-points of the first transition for all variants are 
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established to be around pH 6 with high cooperativity (parameter n is from the equation 
given in the Supplementary Methods section), ranging  from 2.4 to 3.5 for different 
pHLIPs. The second transition is found to be around pH 7.2 with a cooperativity of ranging 
from 0.5 to 1.6. Interestingly, the CD data reporting the coil-helix transformation are 
clearly indicative of a single transition with its midpoint at pH 5.8-5.9 and cooperativity 
ranging from 1.8 to 2.4 for the different pHLIP variants. Note that the transition midpoint 
is a relatively well defined and stable parameter, while the measured cooperativity is less 
well determined and might vary over a relatively wide range within experimental error. 
The local changes reported by the Trp locations and the general peptide changes reported 
by CD might be expected to vary from each other, since these parameters might reflect 
different processes. The high pH transition observed in the fluorescence signal reflects the 
protonation-deprotonation event, which might be associated with partitioning of regions of 
the peptide into the lipid bilayer, but not directly associated with the coil-helix transition. 
The most significant differences occur at the N-terminal part of the pHLIP peptide.  
To gain more insight into the locations of Trp residues at different pHs, we carried out Trp 
fluorescence quenching measurements (Figure 2 and Table 1). The emission of Trp 
residues was measured at different pHs at increasing concentrations of acrylamide, which 
is an effective quencher of Trp fluorescence. PFAST analysis was used to calculate Stern-
Volmer constants (25, 26) and to calculate the percentage of quenching. At pH 8 and pH 5 
the Stern-Volmer plots for all peptide variants demonstrate linear behavior with some 
upward curvature (Figure 2A and 2D). The upward curvature in quenching by acrylamide 
was observed before and attributed to the exponential distance-dependent rate of quenching 
(27).  At intermediate pH of 6 a deviation from linearity is  observed (Figure 2C), 
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potentially reflecting the existence of different populations of pHLIPs, where Trp residues 
are located in different environments and their emission is quenched differently by 
acrylamide (28). Figure 2E and Table 1 reflect gradual decreases of acrylamide quenching 
of Trp fluorescence with decreases of pH, which can be attributed to the partitioning of Trp 
residues into the membrane at lower pH and reduction of accessibility to the quencher. The 
smallest quenching among all pHLIP variants at low pH was observed for the W6 pHLIP 
variant, reflecting a more solvent-exposed position for Trp6, which correlates well with its 
higher long-wavelength emission at low pH compared to Trp17 and Trp30.   
Insertion and exit kinetics measurements were triggered by a pH drop from 8 to 4 and a pH 
raise from 4 to 8, respectively (Supplementary Figure S2). Prior to the pH shift, peptide 
(14 μM) and POPC (2.8 mM) samples were incubated for 24 hrs to reach equilibrium, 
when most of the peptide is associated with the liposomes (1). As we found previously, the 
peptide exit from the membrane is much faster than the insertion into the membrane (2, 3). 
All (or most) protonatable residues in the TM part and at the inserting end of the peptide 
need to be protonated and became neutral to enter the lipid bilayer, which takes time. On 
the other hand, the de-protonation of Asp13 may be enough to induce helix destabilization 
and peptide exit (4), especially when the C-terminal end of the inserted peptide is in its 
neutral state due to the fast equilibration of the pH established between the exterior and 
interior of the liposomes after the pH drop (2). Some differences were observed between 
variants for the insertion and exit kinetics.  
To slow down the kinetic processes and enhance the observed differences we also used 
intermediate pH jumps: from pH 8 to 5.9-6.2 and from pH 4 to 5.8-6.2, monitoring  changes 
of the fluorescence intensity and the position of maxima of fluorescence spectra during 
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peptide insertion and exit. The changes of fluorescence were recorded at different 
wavelengths in a global mode, and fluorescence spectra were restored by data processing 
(Supplementary Figure S3 presents data obtained for Trp30 as an example). Changes of 
Trp emission intensity recorded at different intermediate pH jumps are shown on Figure 3.  
The rates of peptide insertion decrease with decreases of the magnitudes of the pH jumps, 
and the differences in kinetics pathways between variants become more pronounced 
(Figure 3 A-C). Trp6 exhibits insertion kinetics with a reversal “kink” where the 
fluorescence signal first increases, then decays around 15-20 sec after the initiation and is 
then followed by an emission increase (Figure 3A and 4A). Trp17 reaches its final 
destination in the membrane rather quickly (Figure 3B). The insertion of Trp30 into the 
membrane occurs on the time scale of Trp6 and Trp17 insertions. The presence of a “kink” 
for Trp6 was also observed in the kinetics of the CD signal (Figure 4A) and on the graph 
of the intensity ratio (Figure 4B) from the fluorescence spectra recorded in the global mode. 
The ratio is a sensitive measure of the shift of the position of the emission maximum of 
W6 pHLIP variant insertion. A “kink” was also observed for the Trp30 insertion kinetics 
by monitoring intensity changes (Figure 4C) and using the intensity ratio (Figure 4D). The 
data clearly indicate that the propagation of pHLIP peptides into the membrane are 
associated with a series of changes in the microenvironments of the Trp residues. 
The most interesting behavior during the exit of pHLIP variants was observed for Trp30 
(Figure 3F and Figure 5). The fluorescence intensity first increased, then was followed by 
signal decay. The time of the increasing signal was shifted from 1.5 sec in the case of pH 
jump from pH 4 to 5.8 to 0.4 sec in the case of pH jump from pH 4 to 6.2 (with an 
intermediate time of 0.92 sec - for the pH jump from 4 to 6.0). While the build up, which 
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is completed within <2 sec, is difficult to resolve in the global mode, the overall intensity 
decay (Figure 5B) correlates with the 333 nm to 351 nm ratio of emission.  As with the 
insertion measurements, the exit kinetics reveal subtle features not previously observed. 
 
DISCUSSION 
To gain understanding of how a peptide can enter and leave a lipid bilayer, we used the 
pH-triggered insetion and exit of three single-Trp pHLIP variants. We would like to outline 
that the study is a model biophysical and extreme pHs are set to observe completion of the 
transitions. Previously it was shown direct correlation between biophysical studies, 
experiments on cells for delivery of cargo molecules by pHLIP and animal studies for 
targeting of acidic tumors (23, 24). We found a previously unknown transition at high pH 
values that is especially pronounced for the N-terminal part of pHLIP. The transition 
correlates with our recent constant-pH molecular dynamics (MD) calculations, which 
suggest a high flexibility of the N-terminal flanking sequence of pHLIP (4). At different 
pH values in the range of 8.5 to 6.5, pHLIP can adopt various conformational states at a 
bilayer surface, as was noticed previously (6, 8). These conformational changes are not 
associated with helix formation. A further drop of pH induces the familiar bilayer-
associated coil-helix transition, leading to the stabilization of the TM helix at low pH. Trp 
residues at positions 6 and 30 in the pHLIP sequences adopt similar, partially exposed 
positions within the lipid bilayer at the outer and inner leaflets, respectively, after peptide 
insertion, while Trp at position 17 is located near the center. Acrylamide quenching of Trp 
fluorescence confirmed single component emission at high and low pHs, when peptides 
are predominantly equilibrated in the inserted or bilayer-adsorbed states, but heterogeneity 
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was observed at intermediate pH of 6. By monitoring signals from single-Trp pHLIP 
variants, we were able to resolve ambiguities created by the interplay of signals from the 
two Trps  in the WT peptide (9). 
By using pH jumps of different magnitudes, we found intermediates that help us to better 
understand the principles of insertion and exit.  If the pH jump is large enough, e.g. a 
change from pH8 to pH4, it can simultaneously protonate all (or most) of the protonatable 
residues in the membrane inserting part, and the peptide quickly inserts in a TM orientation. 
We previously found that truncation of the C-terminal, inserting part of WT pHLIP can 
enhance the rate of insertion by two orders of magnitude, revealing that protonated but still 
polar C-terminal carboxyl groups can pose a significant barrier for transit of the C-terminus 
across the bilayer, but that entry can still proceed on a timescale of seconds (2, 23). 
However, if the pH jump is to an intermediate value, the concentration of protons in 
solution is not enough to fully shift the equilibrium toward the protonated form of residues 
at the C-terminal part of the peptide, and the peptide is trapped into intermediate states. At 
intermediate pH jumps N- and C-terminal parts of pHLIP alter their positions toward the 
bilayer center, while Trp17 adopts a position deep within the membrane rather quickly, as 
would be consistent with a bent but not inserted conformation. The insertion is completed 
slowly, consistent with a requirement that protonation of most of the Asp/Glu residues is 
needed for peptide insertion to proceed at a significant rate. As suggested by MD 
calculations, and as reasonably expected from the progressively lower dielectric 
environment, the pKa of protonation is shifted toward higher values as Asp, Glu and the 
C-terminus move deeper into the bilayer (4).    
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As previously reported, the exit pathway resulting from a pH raise is different from the 
pathway of insertion (3). Changes in emission of tryptophan at the C-terminal part of 
pHLIP sequence (Trp30) during exit add to our understanding of the process, in which an 
increase of pH leads to the de-protonation of key Asp residues, destabilizing the bilayer-
inserted state, and triggering peptide exit. We observed an increase or “build up” of the 
fluorescence signal, followed by its decay, which clearly documents the exposure of Trp30 
to the non-polar bilayer environment along the pathway of peptide exit from the bilayer. 
The propagation of the C-terminal part of pHLIP through the membrane slows down with 
a decrease of the magnitudes of the pH jumps.  
We believe that our kinetics study, together with recent kinetics experiments on liposomes 
of different thickness of bilayer (5), theoretical (29) and computational (4) work, frames 
an improved understanding of the mechanism of pHLIP peptide insertion and exit from a 
bilayer in response to pH jumps. Figure 6 represents the general scheme of the processes 
as we now understand it. The membrane-adsorbed state is defined as predominantly 
unstructured (extended coil) with the C-terminus facing to the outside of a liposome (or 
extracellular space). The exact position of the peptide at the surface of the bilayer at high 
and neutral pH depends on the pHLIP sequence and lipid composition (6, 7, 24, 30). The 
inserted state is characterized by a transmembrane orientation of the peptide, with the C-
terminal end of the peptide facing the liposome interior (or intracellular space). The 
transition from membrane-adsorbed to inserted states is triggered by pH, which leads to 
the protonation of at least some Asp and Glu residues, increase of peptide hydrophobicity, 
deeper partition into bilayer associated with coli-helix transition. We now recognize a set 
of possible intermediate states, characterized by partially folded structures at the bilayer 
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surface, where the C-terminus is not translocated across the bilayer. The number and nature 
(transient, semi-stable or stable) of intermediate states is dependent on the number of 
protonatable groups or polar (charged) cargoes located at the peptide inserting end (2). 
Charged (or polar) residues and cargoes create forces directed away from the bilayer, which 
reduces the rate of peptide insertion. As we proposed (2) and recently verified (5), the 
predominant driving force for the transition from the helical surface intermediate state to 
the stable membrane inserted state is a relaxation of the membrane distortion created by 
the inclusion of helical structure at the bilayer surface. The presence of helical instability 
around the Pro residue in the middle of the helix provides additional flexibility to complete 
the transition toward a TM orientation. Figure 6 is not a simplified two-state model, it is a 
generalized model to include the behaviors of various pHLIP sequences within membranes 
of different lipid compositions.  
Recently, a multistage model of WT-pHLIP insertion with distinct equilibrium 
thermodynamic intermediates has been proposed (8). While it is interesting to think there 
is a linear progression of states, the fact is that an ensemble of all peptide states exists at 
each pH, so it remains challenging to define a unique succession. At high and low pH 
values the predominant, but still not unique states are the peptide membrane-adsorbed and 
membrane-inserted states, respectively, each of which has a variety of dynamic excursions. 
However, at intermediate pH values a more distributed mixture of states is present as can 
be seen in the kinetics measurements, and complexity is shown by the reversal of the 
fluorescence signal. Of course, in a biological system of living cells in diseased tissues, pH 
gradients exist across cell membranes, with a low pH at the outside surface of a cell and a 
higher pH in the cytoplasm (31).  In a tumor cell , the pH at the cell surface can be below 
89 
6 while the pH inside the cell is thought to be around 7.4. The pH gradient tends to stabilize 
the inserted state, since any C-terminal protonatable residues translocated across the 
membrane into the cytoplasm will be relatively de-protonated in the environment of the 
normal pH of the cytoplasm, which leads to a significant reduction of the rate of peptide 
exit from the membrane.  
Thermodynamics is not limiting for the intracellular delivery of cargo conjugated to pHLIP 
C-terminal inserting end, since the equilibrium of the pHLIP peptide  in a cell with an 
acidic diseased phenotype will be as a TM helix and the chemical potential of the cargo 
will be about the same on either side of the membrane. Given enough time for equilibration, 
even polar or charged cargoes could be delivered into cells and trapped in the cytoplasm. 
However, in a living biological system the circulatory and other dynamics will tend to 
remove uninserted pHLIP complexes, so the kinetics of insertion becomes an  important 
factor for tumor targeting and cargo delivery. Since pHLIPs have a significant affinity for 
bilayer surfaces, they sense the pH at the surfaces of cells in diseased tissues, and when pH 
is low, pHLIPs insert into cellular membrane. The rate of insertion depends on several 
factors: i) the level of acidity in the vicinity of cell membrane; ii) number of polar/charged 
residues at the membrane-inserting end of the peptide and/or polarity/charge of cargo 
molecule (if any), which peptide is translocating (flipping) across membrane, and iii) 
composition, thickness and fluidity of membrane (2, 5).  
While the insertion of pHLIPs across membrane bilayers is of basic scientific interest, the 
possibility of clinical applications for tumor imaging and therapy is emerging as a reality.  
Clinical trials for applications to the targeting of imaging agents are about to start, with the 
first patients being scheduled at the time of this writing, and trials based on targeting tissues 
90 
with a therapeutic agent are anticipated in 2020.  By understanding the principles of pHLIP 
properties, it is likely that future applications can be broadened and improved.  
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Table 1. Tryptophan emission parameters obtained from steady-state fluorescence and CD 
measurements (mean ± standard deviation) are presented. The tryptophan fluorescence 
spectra were processed by PFAST to identify positions of spectral maxima (max). Values 
of max  were averaged over several different steady-state fluorescence measurements. The 
parameters representing transitions induced by a pH drop from 9 to 3, including the 
midpoint  of the pH transition (pK) and cooperativity (n), were calculated by fitting values 
of the position of maximum of fluorescence (Fluor) and ellipticity at 222 nm (CD) 
measured at different pHs.  The Stern-Volmer constants (KSV, M
-1) for acrylamide 
quenching of tryptophan fluorescence of peptides in POPC liposomes at different pHs were 
obtained after PFAST analysis of fluorescence spectra. 
  W6 W17 W30 
max, pH8 (nm) 349.5 ± 0.4 349.2 ± 0.3 352.1 ± 0.4 
max, pH8 + PC (nm) 347.9 ± 0.9 346.9 ± 0.8 350.4 ± 0.3 
max, pH5 + PC (nm) 340.4 ± 0.7 332.3 ± 1.6 339.7 ± 0.9 
Fluor, pK1 6.0 ± 0.0 6.0 ± 0.0 6.1 (fixed) 
Fluor, n1 3.5 ± 0.3 2.6 ± 0.1 2.4 ± 0.2 
Fluor, pK2 7.2 ± 0.1 7.3 ± 0.1 7.2 (fixed) 
Fluor, n2 1.6 ± 0.4 1.2 ± 0.4 0.5 ± 0.1 
CD, pK 5.9 ± 0.0 5.8 ± 0.0 5.8 ± 0.0 
CD, n 2.2 ± 0.2 2.4 ± 0.2 1.8 ± 0.2 
Ksv, pH7.9-8.1 PC (M-1) 20.5 ± 3.5 20.1 ± 2.1 21.2 ± 3.9 
Ksv, pH7.0-7.3 PC (M-1) 19.3 ± 0.5 18.2± 1.1 18.1 ± 0.4 
Ksv, pH5.9-6.2 PC (M-1) 8.0 ± 0.6 11.6 ± 1.7 12.6± 0.7 





Figure 1. pH-dependent bilayer insertion of pHLIP variants. The pH-dependent 
insertion of W6 (A and D), W17 (B and E) and W30 (C and F) pHLIP variants into the 
lipid bilayers of POPC liposomes was studied by monitoring the changes in the position of 
maxima of tryptophan fluorescence spectra (A-C) and ellipticity of CD signals measured 
at 222 nm (D-F) as function of pH. The data were fitted using the Henderson-Hasselbalch 
equation, the fitting curves and 95% confidence interval are shown by red and pink areas, 
respectively. 
 
Figure 2. Acrylamide quenching. Quenching of tryptophan fluorescence of W6, W17 and 
W30 pHLIP variants in presence of POPC liposomes at the range of pH values: pH7.9-8.1 
(A), pH7.0-7.3 (B), pH5.9-6.2 (C), pH4.8-5.0 (D) are presented. The percentage of 
quenching at different pHs calculated for different pHLIP variants is shown in panel E, 
assuming quenching of tryptophan in solution by acrylamide (21 M-1) to be 100%.  
 
Figure 3. Kinetics of insertion and exit. Representative kinetic curves for the insertion 
(A-C) of W6 (A, D), W17 (B, E) and W30 (C, F) pHLIP variants into the lipid bilayer 
triggered by drops of pH from pH8 to pHs 5.8, 6.0 and 6.2, and for the exit (D-F) of W6 
(A, D), W17 (B, E) and W30 (C, F) pHLIP variants out of the lipid bilayer triggered by 
raises of pH from pH4 to pHs 5.8, 6.0 and 6.2 are shown. The normalized fluorescence 
measured via 320 cut off filter is presented. 
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Figure 4. Kinetics of insertion. Representative kinetic curves for the insertion of W6 (A, 
B) and W30 (C, D) pHLIP variants into the lipid bilayer triggered by drops of pH from 
pH8 to pH5.8-5.9, and from pH8 to pH6.2, respectively, are shown. The peptides insertion 
was monitored by changes of fluorescence intensity (A, C) and ratios of fluorescence 
measured at different wavelengths in the global mode kinetics experiments (B, D). The W6 
pHLIP variant folding and unfolding was monitored by changes of the CD signal (A). Red 
curves in panels B, C and D represent averages of the measured signal shown in black. 
 
Figure 5. Kinetics of exit. Representative kinetic curves for the exit of the W30 pHLIP 
variant from the lipid bilayer triggered by raises of pH from pH4 to pHs 5.8, 6.0 and 6.2 
are shown. The peptide exit from the membrane was monitored by changes of fluorescence 
intensity (A, B) and ratio of fluorescence measured at different wavelengths in global mode 
kinetics experiments (C). Red curve at panel C represents averaged of the measured signal 
shown in black. 
 
Figure 6. Model of pHLIP insertion and exit. Schematic presentation of pHLIP folding 
and insertion into a bilayer, as well as the pHLIP exit and unfolding are shown. 
Approximate locations of Trp6, Trp17 and Trp30 are shown by green, blue and yellow 
colors, respectively. The structure of WT pHLIP in the membrane-inserted state was taken 












































Peptides were synthesized and purified by CSBio (Menlo Park, CA). Purified peptides 
were dissolved in 6 M urea and passed through a G-10 size exclusion spin column to 
transfer to 10 mM phosphate buffer, pH 8. Peptide concentrations were calculated using 
absorbance measurements at 280 nm, where 𝜀280 = 8,520⁡𝑀
−1 ∙ 𝑐𝑚−1.  
Liposome Preparations 
Small unilamellar vesicles were prepared by extrusion. 1-Palmitoyl-2-oleoyl-sn-glycero-
3-phosphocholine (POPC, Avanti Polar Lipids, Inc.) dissolved in chloroform at a 
concentration of 12.5 mg/ml was desolvated in a rotary evaporator to create a phospholipid 
film and placed under high vacuum for 2 hours. Lipids were then rehydrated in phosphate 
buffer (pH 8) and extruded through membranes with pore size of 50 nm. The liposome size 
distribution was measured  using a nanoparticle tracking system, Nanosight (NS300, 
Malvern). 
EQUILIBRIUM MEASUREMENTS 
Steady-State fluorescence and CD  
All steady-state spectral measurments including fluorescence, circular dichroism (CD), 
oriented CD (OCD), pH-dependence and acrylamide quenching were performed using a 
PC1 spectrofluorometer (ISS, Inc) and a MOS-450 spectrometer (Biologic, Inc with 
temperature control set to 25.0°C. Tryptophan fluorescence spectra were recorded from 
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310 to 390 nm with step of 1 or 2 nm using an excitation wavelength of 295 nm. Excitation 
and emission polarizers were set to 54.7° and 0.0°, respectively. CD and OCD spectra were 
recorded from 195 to 260 nm with step of 1 nm. The concentration of peptide and 
liposomes were 7 μM and 1.4 mM, respectively. 
Oriented CD  
OCD measurements were conducted on supported bilayers deposited on quartz slides using 
a Langmuir-Blodgett system (KSV Nima). Fourteen slides were cleaned using the 
following protocol; sonication for 10 min in cuvette cleaner solution (5% Contrad in 
water), 2-propanol, acetone, 2-propanol, followed by rinsing in deionized water. Finally, 
the slides were immersed in a mixture of concentrated sulfuric acid and hydrogen peroxide 
(3:1 ratio) for 5 min to remove any remaining organic material and then rinsed three times 
in deionized water. The slides were stored in deionized water until the monolayers were 
applied. The POPC monolayers were deposited on the quartz slides using a KSV 
minitrough. For the Langmuir-Blodgett system, POPC dissolved in chloroform solution at 
3 mg/ml was spread on subphase. After allowing chloroform to evaporate, the POPC 
monolayer was compressed to 32 mN/m. The initial layers on the slides were deposited by 
retrieving the slide from the subphase at a rate of 15 mm/min, and the second layer was 
added by introducing a solution of 10 μM peptide and 1 mM POPC liposomes (50-nm in 
size) at pH 4, resulting in the creation of the supported bilayer via fusion of one layer with 
liposomes. After incubation for 6 h at 100% humidity, excess vesicles were carefully 
removed, buffer at pH 4 was added to the spaces between slides, and the slides were stacked 
with 0.2-mm spacers. CD measurements were taken at three time points: immediately after 
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the addition of the peptide/liposome solution (0 h), after 6 h and 12 h of incubation time 
(6 h and 12 h).  
pH dependence  
The pH-dependent insertion of the peptides into the lipid bilayer of liposomes was studied 
by monitoring either the changes in tryptophan fluorescence spectra or changes in the molar 
ellipticity at 222 nm as a function of pH. After the addition of aliquots of citric acid, the 
pHs of solutions containing 7 μM peptide and 1.4 mM POPC liposomes were measured 
using an Orion PerHecT ROSS Combination pH Micro Electrode and an Orion Dual Star 
pH and ISE Benchtop Meter before and after each spectrum measurement to ensure that 
equilibrium is achieved. The tryptophan fluorescence at each pH was measured on a PC1 
spectrofluorometer. Fluorescence spectra were analyzed using the Protein Fluorescence 
and Structural Tool Kit (PFAST) to determine the positions of spectral maxima (λmax). 
Finally, λmax or millidegree were plotted as a function of pH. The pH-dependence was fit 
with the Henderson-Hasselbach equation (using OriginLab software) to determine the 





Acrylamide quenching  
Tryptophan fluorescence quenching experiments were conducted using acrylamide in the 
cuvette of 3 x 3 mm. Solutions containing 7 μM of pHLIP peptides and 1.4 mM of POPC 
liposomes were adjusted to about pH 8, 7, 6, or 5. Tryptophan fluorescence quenching was 
achieved by addition of increasing amounts of acrylamide. Different amounts of 
acrylamide used for different pH values (the maximum was 0.2-0.3 M of acrylamide for 
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measurements performed at low pH). The obtained data were corrected for the dilution and 
inner filter effect taking into account that the exctiction coefficient for acrylamide at 295 
nm is 0.25 M-1cm-1. PFAST analysis was employed to calculate Stern-Volmer constants 
and to calculate the percentage of quenching (100% was assigned to the quenching of 
tryptophan in solution, KSV = 21 M
-1).  
Kinetics Measurements  
Tryptophan fluorescence and CD kinetics were measured using a SFM-300 mixing system 
(Bio-Logic Science Instruments) in combination with the MOS-450 spectrometer with 
temperature control set to 25.0°C. All samples were degassed before measurements to 
minimize air bubbles in the samples. Peptide (14 μM) and POPC (2.8 mM) samples were 
incubated for 24 hrs to reach equilibrium, when most of the peptide is associated with 
liposome lipid bilayers. To follow peptide insertion, equal volumes of peptide-POPC 
solution and citric acid were fast mixed (5-ms dead time) to lower the pH from pH 8 to the 
desired lower pH value. To measure peptide exit, equal volumes of peptide-POPC solution 
and disodium phosphate were mixed to raise the pH from pH 4 to the desired higher pH 
value. To monitor fluorescence intensity changes during peptide insertion or exit, the 
tryptophan emission signal was observed through a cut off 320 nm filter at an excitation of 
295 nm. To monitor the shift of the entire tryptophan spectra of the peptides during 
insertion and exit, (excited at 295 nm) an emission monochromator was used. In the latter 
case, fluorescence kinetics spectra were recorded in a global mode at individual emission 
wavelengths from 321 nm to 366 nm with steps of 3 nm. Three-dimensional plots were 
constructed reflecting changes in fluorescence intensity, time, and wavelength. Two-
dimensional plots were made by taking cross sections at particular times and plotting 
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intensity vs. wavelength. To monitor coil-helix transition (and vice versa) the CD signal at 
222 nm was recorded.  
Data analysis 
All data were fit to the appropriate equations by nonlinear least squares curve fitting 




Figure S1. Tryptophan fluorescence (A-C), CD and OCD (D-F) spectra are shown from 
Trp6 (A, D), Trp17 (B, E) and Trp30 (C, F) pHLIP variants: in aqueous solution at pH 8 
(black lines), at pH8 in the presence of POPC liposomes (blue lines) and at pH4 in the 
presence of POPC liposomes (red lines). Oriented circular dichroism (OCD) signals 




Figure S2. Trp fluorescence kinetics measurements of pHLIP peptide insertion and exit  
are shown over different time scales for Trp6 (black lines), Trp17 (blue lines), and Trp30 
(red lines) pHLIP variants. Insertion is triggered by a pH jump from pH8 to pH4 (A, B) 











Figure S3. 3D (A, C) and 2D (B, D) representations are shown for the insertion (A, B) and 
exit (C, D) kinetics of Trp30, on the inserting C-terminal flank of the pHLIP peptide. 
Spectral regions of the fluorescence reveal complex pathways, as in the short wavelengths 
for insertion seen in A.  
The 3D plots (A, C) reflect changes in fluorescence intensity, time, and wavelength (the 
axis are the same on both panels, but angle views are different for better presentation). The 
2D plots (B, D) show cross sections of the 3D plots at selected time points.  
 
